THERMO ELECTRON CORP
10-K/A, 1995-08-02
MEASURING & CONTROLLING DEVICES, NEC
Previous: ADVANTA CORP, 424B2, 1995-08-02
Next: TODD SHIPYARDS CORP, 10-Q, 1995-08-02



                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                         AMENDMENT NO. 2 ON FORM 10-K/A

   (mark one)
   [ X ] Annual Report Pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934 for the fiscal year ended December 31, 1994

   [   ] Transition Report Pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934

                          Commission file number 1-8002

                           THERMO ELECTRON CORPORATION
             (Exact name of Registrant as specified in its charter)
   Delaware                                                         04-2209186
   (State or other jurisdiction of                            (I.R.S. Employer
   incorporation or organization)                          Identification No.)

   81 Wyman Street, P.O. Box 9046
   Waltham, Massachusetts                                           02254-9046
   (Address of principal executive offices)                         (Zip Code)
       Registrant's telephone number, including area code: (617) 622-1000

           Securities registered pursuant to Section 12(b) of the Act:

                                                         Name of each exchange
   Title of each class                                     on which registered
   Common Stock, $1.00 par value                       New York Stock Exchange
   Preferred Stock Purchase Rights
           Securities registered pursuant to Section 12(g) of the Act:
                                      None

   Indicate by check mark whether the Registrant (1) has filed all reports
   required to be filed by Section 13 or 15(d) of the Securities Exchange Act
   of 1934 during the preceding 12 months, and (2) has been subject to the
   filing requirements for at least the past 90 days. Yes [ X ]   No [   ]

   Indicate by check mark if disclosure of delinquent filers pursuant to Item
   405 of Regulation S-K is not contained herein, and will not be contained,
   to the best of the Registrant's knowledge, in definitive proxy or
   information statements incorporated by reference into Part III of this Form
   10-K or any amendment to this Form 10-K. [  ]

   The aggregate market value of the voting stock held by nonaffiliates of the
   Registrant as of January 27, 1995, was approximately $2,200,490,000.

   As of January 27, 1995, the Registrant had 51,000,776 shares of Common
   Stock outstanding.

                       DOCUMENTS INCORPORATED BY REFERENCE

   Portions of the Registrant's Annual Report to Shareholders for the year
   ended December 31, 1994, are incorporated by reference into Parts I and II.

   Portions of the Registrant's definitive Proxy Statement for the Annual
   Meeting of Shareholders to be held on May 23, 1995, are incorporated by
   reference into Part III.
PAGE
<PAGE>
                                                                   FORM 10-K/A
                           THERMO ELECTRON CORPORATION



   Item 14.  Exhibits, Financial Statement Schedules, and Reports on Form 8-K

             (c) Exhibits

                13   Annual Report to Shareholders for the year ended
                     December 31, 1994 (only those portions incorporated
                     herein by reference)

                23   Consent of Arthur Andersen LLP

                27   Financial Data Schedule

        Attached is Exhibit 13 of the Registrant's Form 10-K for the year
   ended December 31, 1994. The Registrant's financial statements have been
   restated to reflect the March 15, 1995 acquisition of Coleman Research
   Corporation which has been accounted for under the pooling-of-interests
   method and to reflect a three-for-two stock split, effected in the form of
   a 50% stock dividend, that was distributed in May 1995. This amended
   information replaces the corresponding information filed originally in the
   Form 10-K.



































                                        2PAGE
<PAGE>
                                                                   FORM 10-K/A
                           THERMO ELECTRON CORPORATION




                                   SIGNATURES


        Pursuant to the requirements of the Securities Exchange Act of 1934,
   the Registrant has duly caused this report to be signed on its behalf by
   the udnersigned thereunto duly authorized, on this 1st day of August 1995.

                                           THERMO ELECTRON CORPORATION



                                           Paul F. Kelleher
                                           ---------------------------
                                           Paul F. Kelleher
                                           Vice President, Finance and
                                           Administration



































                                       3PAGE
<PAGE>


                                                                    Exhibit 13













                           THERMO ELECTRON CORPORATION


                            1994 Financial Statements
PAGE
<PAGE>
  Thermo Electron Corporation
  Consolidated Statement of Income

  (In thousands except per share amounts)       1994        1993        1992
  --------------------------------------------------------------------------
  Revenues:
   Product revenues                        $1,418,306 $1,103,558  $  808,928
   Service revenues                           141,438    121,987     114,268
   Research and development contract
    revenues                                  169,447    128,963      76,032
                                           ---------- ----------  ----------
                                            1,729,191  1,354,508     999,228
                                           ---------- ----------  ----------
  Costs and Expenses:
   Cost of products                           824,845    664,201     521,668
   Cost of services                           103,800     91,292      87,307
   Expenses for research and development
    and new lines of business (a)             233,099    183,965     106,466
   Selling, general and administrative
    expenses                                  384,715    289,282     213,266

   Costs associated with divisional and
    product restructuring (Note 12)               650      6,616           -
                                           ---------- ----------  ----------
                                            1,547,109  1,235,356     928,707
                                           ---------- ----------  ----------
  Operating Income                            182,082    119,152      70,521
  Gain on Issuance of Stock by
   Subsidiaries (Note 10)                      25,283     39,863      30,212
  Other Income (Expense), Net (Note 11)          (989)   (27,548)      1,842
                                           ---------- ----------  ----------
  Income Before Income Taxes, Minority
   Interest, and Cumulative Effect of
   Change in Accounting Principle             206,376    131,467     102,575
  Provision for Income Taxes (Note 9)          70,703     33,513      27,750
  Minority Interest Expense                    30,962     21,086      13,902
                                           ---------- ----------  ----------
  Income Before Cumulative Effect of
   Change in Accounting Principle             104,711     76,868      60,923
  Cumulative Effect of Change in
   Accounting Principle, Net of
   Tax (Note 8)                                     -          -       1,438
                                           ---------- ----------  ----------
  Net Income                               $  104,711 $   76,868  $   59,485
                                           ========== ==========  ==========
  Before Cumulative Effect of Change in
   Accounting Principle:
    Primary earnings per share             $     1.35 $     1.11  $      .95
                                           ========== ==========  ==========
    Fully diluted earnings per share       $     1.20 $     1.00  $      .90
                                           ========== ==========  ==========
  Primary Earnings per Share               $     1.35 $     1.11  $      .93
                                           ========== ==========  ==========
  Fully Diluted Earnings per Share         $     1.20 $     1.00  $      .88
                                           ========== ==========  ==========
  Primary Weighted Average Shares              77,667     69,468      63,874
                                           ========== ==========  ==========
  Fully Diluted Weighted Average Shares       100,819     87,079      74,545
                                           ========== ==========  ==========
                                       2PAGE
<PAGE>
  Thermo Electron Corporation
  Consolidated Statement of Income (continued)


  (In thousands)                                1994        1993        1992
  --------------------------------------------------------------------------
  (a) Includes costs of:
       Research and development contracts  $  149,645 $  116,733  $   63,336
       Internally funded research and
        development                            79,555     59,583      38,888
       Other expenses for new lines of
        business                                3,899      7,649       4,242
                                           ---------- ----------  ----------
                                           $  233,099 $  183,965  $  106,466
                                           ========== ==========  ==========

  The accompanying notes are an integral part of these consolidated financial
  statements.








































                                       3PAGE
<PAGE>
  Thermo Electron Corporation
  Consolidated Balance Sheet

  (In thousands)                                          1994        1993
  ------------------------------------------------------------------------
  Assets
  Current Assets:
   Cash and cash equivalents                        $  383,005  $  325,989
   Short-term available-for-sale investments,
    at quoted market value (amortized cost
    of $617,837) (Note 2)                              614,915           -
   Short-term investments, at cost (quoted
    market value of $377,183)                                -     374,450
   Accounts receivable, less allowances
    of $21,664 and $14,174                             347,444     281,223
   Unbilled contract costs and fees                     59,906      45,108
   Inventories:
    Raw materials and supplies                         128,876     110,437
    Work in process                                     44,711      38,055
    Finished goods                                      59,795      44,330
   Prepaid income taxes (Note 9)                        57,824      35,996
   Prepaid expenses                                     15,148      12,705
                                                    ----------  ----------
                                                     1,711,624   1,268,293
                                                    ----------  ----------
  Assets Related to Projects Under Construction:
   Restricted funds, at quoted market value                  -      34,100
   Facilities under construction                             -     128,040
                                                    ----------  ----------
                                                             -     162,140
                                                    ----------  ----------
  Property, Plant and Equipment, at Cost:
   Land                                                 43,990      40,570
   Buildings                                           143,727     116,895
   Alternative-energy and waste-recycling
    facilities                                         335,064     199,800
   Machinery, equipment and leasehold improvements     288,544     237,558
                                                    ----------  ----------
                                                       811,325     594,823
   Less: Accumulated depreciation and amortization     186,437     139,203
                                                    ----------  ----------
                                                       624,888     455,620
                                                    ----------  ----------
  Long-term Available-for-sale Investments, at 
   Quoted Market Value (amortized cost of $65,218)
   (Note 2)                                             62,451           -
                                                    ----------  ----------
  Long-term Marketable Securities, at Cost
   (quoted market value of $45,125)                          -      43,630
                                                    ----------  ----------
  Other Assets                                          85,338     102,347
                                                    ----------  ----------
  Cost in Excess of Net Assets of Acquired
   Companies (Note 3)                                  577,634     475,567
                                                    ----------  ----------
                                                    $3,061,935  $2,507,597
                                                    ==========  ==========

  The accompanying notes are an integral part of these consolidated financial
  statements.


                                       4PAGE
<PAGE>
  Thermo Electron Corporation
  Consolidated Balance Sheet (continued)

  (In thousands except share amounts)                     1994        1993
  ------------------------------------------------------------------------
  Liabilities and Shareholders' Investment
  Current Liabilities:
   Notes payable and current maturities of
    long-term obligations (Note 6)                  $   94,003  $   70,113
   Accounts payable                                    116,768      90,152
   Accrued payroll and employee benefits                79,849      56,557
   Accrued income taxes                                 35,845       7,713
   Accrued installation and warranty costs              33,442      26,049
   Other accrued expenses (Note 3)                     200,985     183,870
                                                    ----------  ----------
                                                       560,892     434,454
                                                    ----------  ----------
  Deferred Income Taxes (Note 9)                        58,250      48,738
                                                    ----------  ----------
  Other Deferred Items                                  57,723      58,152
                                                    ----------  ----------
  Liabilities Related to Projects Under
   Construction (Note 6):
    Payables and accrued expenses                            -      10,680
    Tax-exempt obligations                                   -     142,069
                                                    ----------  ----------
                                                             -     152,749
                                                    ----------  ----------
  Long-term Obligations (Note 6):
   Senior convertible obligations                      620,000     275,000
   Subordinated convertible obligations                186,661     238,386
   Tax-exempt obligations                              130,985           -
   Nonrecourse tax-exempt obligations                   95,300     108,800
   Other                                                16,904      25,406
                                                    ----------  ----------
                                                     1,049,850     647,592
                                                    ----------  ----------
  Minority Interest                                    327,734     277,681
                                                    ----------  ----------
  Commitments and Contingencies (Note 7)

  Common Stock of Subsidiary Subject to
   Redemption ($15,390 redemption value)                     -      14,511
                                                    ----------  ----------
  Shareholders' Investment (Notes 4 and 5):
   Preferred stock, $100 par value, 50,000
    shares authorized; none issued
   Common stock, $1 par value, 175,000,000
    shares authorized; 53,558,248 and
    50,483,488 shares issued                            53,558      50,484
   Capital in excess of par value                      493,058     474,193
   Retained earnings                                   472,396     367,685
   Treasury stock at cost, 38,318 and 31,898
    shares                                              (1,631)     (1,212)
   Cumulative translation adjustment                    (3,557)    (13,591)
   Deferred compensation (Note 8)                       (2,657)     (3,839)


                                       5PAGE
<PAGE>
  Thermo Electron Corporation
  Consolidated Balance Sheet (continued)

  (In thousands except share amounts)                     1994        1993
  ------------------------------------------------------------------------
   Net unrealized loss on available-for-sale
    investments (Note 2)                                (3,681)          -
                                                    ----------  ----------
                                                     1,007,486     873,720
                                                    ----------  ----------
                                                    $3,061,935  $2,507,597
                                                    ==========  ==========

  The accompanying notes are an integral part of these consolidated financial
  statements.











































                                       6PAGE
<PAGE>
  Thermo Electron Corporation
  Consolidated Statement of Cash Flows

  (In thousands)                                1994        1993       1992
  -------------------------------------------------------------------------
  Operating Activities:
   Net income                              $ 104,711  $  76,868   $  59,485
   Adjustments to reconcile net income
    to net cash provided by operating
    activities:
     Cumulative effect of change in
      accounting principle (Note 8)                -          -       1,438
     Depreciation and amortization            65,028     44,192      30,463
     Costs associated with divisional
      and product restructuring
      (Note 12)                                  650      6,616           -
     Equity in losses of unconsolidated
      subsidiaries                             4,019     22,721       3,948
     Provision for losses on accounts
      receivable                               4,255      2,675       2,021
     Increase in deferred income taxes         9,403     14,134      12,374
     Gain on sale of property, plant
      and equipment                          (15,025)      (198)       (175)
     Gain on sale of investments              (4,851)    (2,469)     (4,968)
     Gain on issuance of stock by
      subsidiaries (Note 10)                 (25,283)   (39,863)    (30,212)
     Minority interest expense                30,962     21,086      13,902
     Other noncash expenses                    9,809      7,850      11,549
     Changes in current accounts,
      excluding the effects of
      acquisitions:
       Accounts receivable                    (8,556)   (44,989)    (11,030)
       Inventories                            10,017     (6,525)     (4,753)
       Other current assets                   (9,713)    (8,319)    (14,099)
       Accounts payable                          804     13,865      (1,676)
       Other current liabilities              16,295     (6,319)     (3,323)
                                           ---------  ---------   ---------
        Net cash provided by operating
         activities                          192,525    101,325      64,944
                                           ---------  ---------   ---------
  Investing Activities:
   Acquisitions, net of cash acquired
    (Note 3)                                (173,764)  (142,962)   (251,738)
   Purchases of available-for-sale
    investments                             (748,879)         -           -
   Proceeds from sale and maturities of
    available-for-sale investments           495,361          -           -
   Purchases of property, plant and
    equipment                                (65,525)   (62,704)    (63,320)
   Proceeds from sale of property,
    plant and equipment                       21,391      5,224       1,609
   Purchases of long-term investments              -    (20,573)    (70,340)
   Proceeds from sale of long-term
    investments                                    -     16,651      35,899
   (Increase) decrease in short-term
    investments                                    -   (193,894)     68,260
   Increase in assets related to
    construction projects                          -     (3,781)   (132,971)


                                       7PAGE
<PAGE>
  Thermo Electron Corporation
  Consolidated Statement of Cash Flows (continued)

  (In thousands)                                1994        1993       1992
  -------------------------------------------------------------------------
   Decrease in net restricted funds           23,420          -           -
   Other                                      (7,662)    (3,516)     (1,137)
                                           ---------  ---------   ---------
        Net cash used in investing
         activities                         (455,658)  (405,555)   (413,738)
                                           ---------  ---------   ---------
  Financing Activities:
   Proceeds from issuance of long-term
    obligations                              368,620    102,282     389,230
   Repayment and repurchase of long-term
    obligations                              (27,176)   (11,732)    (27,539)
   Increase (decrease) in short-term
    notes payable                             16,683     27,343      (8,459)
   Proceeds from issuance of Company
    and subsidiary common stock               60,601    378,790     100,749
   Purchases of Company and subsidiary
    common stock                            (101,481)   (57,198)    (45,334)
   Other                                         987      3,096       2,485
                                           ---------  ---------   ---------
        Net cash provided by financing
         activities                          318,234    442,581     411,132
                                           ---------  ---------   ---------
  Exchange Rate Effect on Cash                 1,915     (3,374)     (2,424)
                                           ---------  ---------   ---------
  Increase in Cash and Cash Equivalents       57,016    134,977      59,914
  Cash and Cash Equivalents at
   Beginning of Year                         325,989    191,012     131,098
                                           ---------  ---------   ---------
  Cash and Cash Equivalents at End
   of Year                                 $ 383,005  $ 325,989   $ 191,012
                                           =========  =========   =========

  See Note 13 for supplemental cash flow information.

  The accompanying notes are an integral part of these consolidated financial
  statements.


















                                       8PAGE
<PAGE>
   Thermo Electron Corporation
   Consolidated Statement of Shareholders' Investment


                                                Common    Capital
                                                Stock,  in Excess
                                                $1 Par     of Par   Retained
   (In thousands)                                Value      Value   Earnings
   -------------------------------------------------------------------------
   Balance December 28, 1991,
    as previously reported                   $ 25,858   $230,251    $226,349
   Acquisition through
    pooling-of-interests                        2,533      1,080       4,983
                                             --------   --------    --------
   Balance December 28, 1991,
    as restated                                28,391    231,331     231,332
   Net income                                       -          -      59,485
   Purchases of Company common
    stock                                           -          -           -
   Private placement of Company
    common stock                                  800     33,455           -
   Issuance of stock under
    employees' and directors'
    stock plans                                   358      4,241           -
   Tax benefit related to
    employees' and directors'
    stock plans                                     -      4,773           -
   Conversion of convertible
    obligations                                    84      2,894           -
   Effect of majority-owned
    subsidiaries' equity
    transactions                                    -    (16,509)          -
   Cumulative translation
    adjustment                                      -          -           -
   Amortization of deferred
    compensation                                    -          -           -
                                             ---------  ---------   --------
   Balance January 2, 1993                     29,633    260,185     290,817
   Net income                                       -          -      76,868
   Public offering of Company
    common stock (Note 4)                       4,500    241,505           -
   Issuance of stock under
    employees' and directors'
    stock plans                                   216        763           -
   Conversion of convertible
    obligations                                   285      6,619           -
   Effect of majority-owned
    subsidiaries' equity
    transactions                                    -    (19,029)          -
   Effect of three-for-two
    stock split                                15,850    (15,850)          -
   Cumulative translation
    adjustment                                      -          -           -
   Amortization of deferred
    compensation                                    -          -           -
                                             --------   --------    --------



                                        9PAGE
<PAGE>
   Thermo Electron Corporation
   Consolidated Statement of Shareholders' Investment (continued)


                                                Common    Capital
                                                Stock,  in Excess
                                                $1 Par     of Par   Retained
   (In thousands)                                Value      Value   Earnings
   -------------------------------------------------------------------------
   Balance January 1, 1994                     50,484    474,193     367,685
   Net income                                       -          -     104,711
   Issuance of stock under
    employees' and directors'
    stock plans                                   153      2,429           -
   Conversion of convertible
    obligations                                 2,921     63,013           -
   Effect of majority-owned
    subsidiaries' equity
    transactions                                    -    (46,577)          -
   Cumulative translation
    adjustment                                      -          -           -
   Amortization of deferred
    compensation                                    -          -           -
   Effect of change in accounting
    principle (Note 2)                              -          -           -
   Change in net unrealized loss
    on available-for-sale
    investments (Note 2)                            -          -           -
                                             --------   --------    --------
   Balance December 31, 1994                 $ 53,558   $493,058    $472,396
                                             ========   ========    ========

   The accompanying notes are an integral part of these consolidated financial
   statements.
























                                       10PAGE
<PAGE>
  Thermo Electron Corporation
  Consolidated Statement of Shareholders' Investment (continued)

                                                                      Net Un-
                                           Cumulative                realized
                                             Transla-                 Loss on
                                                 tion   Deferred   Available-
                                   Treasury   Adjust-  Compensa-     for-sale
  (In thousands)                      Stock      ment       tion  Investments
  ---------------------------------------------------------------------------
  Balance December 28, 1991,
   as previously reported         $ (1,038)  $  5,532   $ (6,010)   $      -
  Acquisition through
   pooling-of-interests                  -          -          -           -
                                  --------   --------   --------    --------
  Balance December 28, 1991,
   as restated                      (1,038)     5,532     (6,010)          -
  Net income                             -          -          -           -
  Purchases of Company common
   stock                            (6,214)         -          -           -
  Private placement of Company
   common stock                          -          -          -           -
  Issuance of stock under
   employees' and directors'
   stock plans                       3,442          -          -           -
  Tax benefit related to
   employees' and directors'
   stock plans                           -          -          -           -
  Conversion of convertible
   obligations                           -          -          -           -
  Effect of majority-owned
   subsidiaries' equity
   transactions                          -          -          -           -
  Cumulative translation
   adjustment                            -    (13,481)         -           -
  Amortization of deferred
   compensation                          -          -        960           -
                                  --------   --------   --------    --------
  Balance January 2, 1993           (3,810)    (7,949)    (5,050)          -
  Net income                             -          -          -           -
  Public offering of Company
   common stock (Note 4)                 -          -          -           -
  Issuance of stock under
   employees' and directors'
   stock plans                       2,598          -          -           -
  Conversion of convertible
   obligations                           -          -          -           -
  Effect of majority-owned
   subsidiaries' equity
   transactions                          -          -          -           -
  Effect of three-for-two
   stock split                           -          -          -           -
  Cumulative translation
   adjustment                            -     (5,642)         -           -
  Amortization of deferred
   compensation                          -          -      1,211           -
                                  --------   --------   --------    --------



                                      11PAGE
<PAGE>
  Thermo Electron Corporation
  Consolidated Statement of Shareholders' Investment (continued)

                                                                      Net Un-
                                           Cumulative                realized
                                             Transla-                 Loss on
                                                 tion   Deferred   Available-
                                   Treasury   Adjust-  Compensa-     for-sale
  (In thousands)                      Stock      ment       tion  Investments
  ---------------------------------------------------------------------------
  Balance January 1, 1994           (1,212)   (13,591)    (3,839)          -
  Net income                             -          -          -           -
  Issuance of stock under
   employees' and directors'
   stock plans                        (419)         -          -           -
  Conversion of convertible
   obligations                           -          -          -           -
  Effect of majority-owned
   subsidiaries' equity
   transactions                          -          -          -           -
  Cumulative translation
   adjustment                            -     10,034          -           -
  Amortization of deferred
   compensation                          -          -      1,182           -
  Effect of change in accounting
   principle (Note 2)                    -          -          -       2,868
  Change in net unrealized loss
   on available-for-sale
   investments (Note 2)                  -          -          -      (6,549)
                                  --------   --------   --------    --------
  Balance December 31, 1994       $ (1,631)  $ (3,557)  $ (2,657)   $ (3,681)
                                  ========   ========   ========    ========

  The accompanying notes are an integral part of these consolidated financial
  statements.























                                      12PAGE
<PAGE>
  Thermo Electron Corporation
  Notes to Consolidated Financial Statements

  1.  Significant Accounting Policies

  Principles of Consolidation
  The accompanying consolidated financial statements include the accounts of
  Thermo Electron Corporation and its majority- and wholly owned subsidiaries
  (the Company). All material intercompany accounts and transactions have
  been eliminated. Majority-owned public subsidiaries include Thermedics
  Inc., Thermo Instrument Systems Inc., Thermo Process Systems Inc., Thermo
  Power Corporation, ThermoTrex Corporation, Thermo Fibertek Inc., and Thermo
  Ecotek Corporation (formerly Thermo Energy Systems Corporation) (Note 15).
  Thermo Cardiosystems Inc. and Thermo Voltek Corp. are majority-owned public
  subsidiaries of Thermedics. Thermo Remediation Inc. is a majority-owned
  public subsidiary of Thermo Process. ThermoLase Corporation is a
  majority-owned public subsidiary of ThermoTrex. ThermoSpectra Corporation
  is a majority-owned, privately held subsidiary of Thermo Instrument. The
  Company accounts for investments in businesses in which it owns between 20%
  and 50% using the equity method.

  Fiscal Year
  The Company has adopted a fiscal year ending the Saturday nearest December
  31. References to 1994, 1993, and 1992 are for the fiscal years ended
  December 31, 1994, January 1, 1994, and January 2, 1993, respectively.
  Fiscal years 1994 and 1993 each included 52 weeks; 1992 included 53 weeks.

  Revenue Recognition
  For the majority of its operations, the Company recognizes revenues upon
  shipment of its products or upon completion of services it renders. The
  Company provides a reserve for its estimate of warranty and installation
  costs at the time of shipment. Revenues and profits on substantially all
  contracts are recognized using the percentage-of-completion method.
  Revenues recorded under the percentage-of-completion method were
  $319,769,000 in 1994, $281,417,000 in 1993, and $236,663,000 in 1992. The
  percentage of completion is determined by relating either the actual costs
  or actual labor incurred to date to management's estimate of total costs or
  total labor, respectively, to be incurred on each contract. If a loss is
  indicated on any contract in process, a provision is made currently for the
  entire loss. The Company's contracts generally provide for billing of
  customers upon the attainment of certain milestones specified in each
  contract. Revenues earned on contracts in process in excess of billings are
  classified as "Unbilled contract costs and fees" in the accompanying
  balance sheet. There are no significant amounts included in the
  accompanying balance sheet that are not expected to be recovered from
  existing contracts at current contract values, or that are not expected to
  be collected within one year, including amounts that are billed but not
  paid under retainage provisions.
       In August 1993, the Company agreed, in exchange for a cash settlement,
  to terminate a power sales agreement between a subsidiary of the Company
  and a utility. The power sales agreement required the utility to purchase
  output of a cogeneration facility that had been under development. Under
  the termination agreement, the Company received $12.6 million through 1994,
  with subsequent payments of $5.4 million to be made through 1997. The
  Company will be obligated to return $8.2 million of this settlement if the
  Company elects to proceed with the facility and it achieves commercial
  operation before January 1, 2000. Accordingly, the Company has deferred
  recognition of $8.2 million of revenues, pending final determination of the
  project's status. During 1993, the Company recorded revenues of $9.8

                                      13PAGE
<PAGE>
  Thermo Electron Corporation


  million and segment income of $5.4 million from the termination of the
  power sales agreement.

  Gain on Issuance of Stock by Subsidiaries
  At the time a subsidiary sells its stock to unrelated parties at a price in
  excess of its book value, the Company's net investment in that subsidiary
  increases. If at that time the subsidiary is an operating entity and not
  engaged principally in research and development, the Company records the
  increase as a gain.
       If gains have been recognized on issuances of a subsidiary's stock and
  shares of the subsidiary are subsequently repurchased by the subsidiary or
  by the Company, gain recognition does not occur on issuances subsequent to
  the date of a repurchase until such time as shares have been issued in an
  amount equivalent to the number of repurchased shares. Such transactions
  are reflected as equity transactions and the net effect of these
  transactions is reflected in the accompanying statement of shareholders'
  investment as "Effect of majority-owned subsidiaries' equity transactions."

  Income Taxes
  In accordance with Statement of Financial Accounting Standards (SFAS) No.
  109, "Accounting for Income Taxes," the Company recognizes deferred income
  taxes based on the expected future tax consequences of differences between
  the financial statement basis and the tax basis of assets and liabilities,
  calculated using enacted tax rates in effect for the year in which the
  differences are expected to be reflected in the tax return.

  Earnings per Share
  Primary earnings per share have been computed based on the weighted average
  number of common shares outstanding during the year. Because the effect of
  common stock equivalents was not material, they have been excluded from the
  primary earnings per share calculation. Fully diluted earnings per share
  assumes the exercise of stock options and the conversion of the Company's
  dilutive convertible obligations and elimination of the related interest
  expense.

  Stock Split
  All share and per share information was restated to reflect a three-for-two
  stock split, effected in the form of a 50% stock dividend, that was
  distributed in October 1993 (Note 15).

  Cash and Cash Equivalents
  Cash equivalents consist principally of U.S. government agency securities,
  bank time deposits, and commercial paper purchased with an original
  maturity of three months or less. These investments are carried at cost,
  which approximates market value.

  Available-for-sale Investments
  Pursuant to SFAS No. 115, "Accounting for Certain Investments in Debt and
  Equity Securities," the Company's short- and long-term debt and marketable
  equity securities are accounted for at market value (Note 2). Prior to
  1994, these investments were carried at the lower of cost or market value.
  The fair market value of short- and long-term investments is determined
  based on quoted market prices for those investments.






                                      14PAGE
<PAGE>
  Thermo Electron Corporation


  Inventories
  Inventories are stated at the lower of cost (on a first-in, first-out or
  weighted average basis) or market value and include materials, labor, and
  manufacturing overhead.

  Property, Plant and Equipment
  The costs of additions and improvements are capitalized, while maintenance
  and repairs are charged to expense as incurred. The Company provides for
  depreciation and amortization using the straight-line method over the
  estimated useful lives of the property as follows: buildings and
  improvements -- 5 to 40 years, alternative-energy and waste-recycling
  facilities -- 24 to 25 years, machinery and equipment -- 3 to 20 years, and
  leasehold improvements -- the shorter of the term of the lease or the life
  of the asset.

  Assets Related to Projects Under Construction
  "Facilities under construction" in the accompanying 1993 balance sheet
  included a waste-recycling facility that was under construction in San
  Diego County, California. Construction costs for this facility were
  capitalized as incurred. Construction was completed in early 1994. This
  facility is included in "Alternative-energy and waste-recycling facilities"
  in the accompanying 1994 balance sheet.
       "Restricted funds" in the accompanying 1993 balance sheet represented
  unexpended proceeds from the issuance of tax-exempt obligations (Note 6),
  which were invested principally in U.S. government agency securities and
  municipal tax-exempt obligations. These investments were carried at cost,
  which equaled market value at year-end 1993.

  Other Assets
  "Other assets" in the accompanying balance sheet includes the cost of
  acquired trademarks, patents, and other specifically identifiable
  intangible assets, as well as capitalized costs associated with the
  Company's operation of certain alternative-energy facilities. These assets
  are being amortized using the straight-line method over their estimated
  useful lives, which range from 5 to 20 years. These assets were $39,731,000
  and $41,252,000, net of accumulated amortization of $21,741,000 and
  $16,699,000, at year-end 1994 and 1993, respectively.

  Cost in Excess of Net Assets of Acquired Companies
  The excess of cost over the fair value of net assets of acquired businesses
  is amortized using the straight-line method principally over 40 years.
  Accumulated amortization was $47,273,000 and $32,902,000 at year-end 1994
  and 1993, respectively. The Company assesses the future useful life of this
  asset whenever events or changes in circumstances indicate that the current
  useful life has diminished. The Company considers the future undiscounted
  cash flows of the acquired businesses in assessing the recoverability of
  this asset.

  Common Stock of Subsidiary Subject to Redemption
  In March 1993, ThermoLase sold 6,156,000 units at $2.50 per unit, each unit
  consisting of one share of ThermoLase common stock and one redemption
  right. In accordance with their terms, the redemption rights expired in
  November 1994 and, as a result, the Company transferred $14,765,000 of
  "Common stock of subsidiary subject to redemption" to "Minority interest"
  and "Capital in excess of par value."




                                      15PAGE
<PAGE>
  Thermo Electron Corporation


  Foreign Currency
  All assets and liabilities of the Company's foreign subsidiaries are
  translated at year-end exchange rates, and revenues and expenses are
  translated at average exchange rates for the year in accordance with SFAS
  No. 52, "Foreign Currency Translation." Resulting translation adjustments
  are reflected as a separate component of shareholders' investment titled
  "Cumulative translation adjustment." Foreign currency transaction gains and
  losses are included in the accompanying statement of income and are not
  material for the three years presented.

  Presentation
  The historical financial information presented has been restated to reflect
  the March 15, 1995 acquisition of Coleman Research Corporation (Coleman
  Research), which has been accounted for under the pooling-of-interests
  method (Note 15). 
       Certain amounts in 1993 and 1992 have been reclassified to conform to
  the 1994 financial statement presentation.


  2.  Available-for-sale Investments

  Effective January 2, 1994, the Company adopted SFAS No. 115, "Accounting
  for Certain Investments in Debt and Equity Securities." In accordance with
  SFAS No. 115, the Company's debt and marketable equity securities are
  considered "Available-for-sale investments" in the accompanying balance
  sheet and are carried at market value, with the difference between cost and
  market value, net of related tax effects, recorded currently as a component
  of shareholders' investment titled "Net unrealized loss on available-for-
  sale investments." "Effect of change in accounting principle" in the
  accompanying statement of shareholders' investment represents the
  unrealized gain, net of related tax effects, pertaining to available-for-
  sale investments held by the Company on January 2, 1994.
       The aggregate market value, cost basis, and gross unrealized gains and
  losses of short- and long-term available-for-sale investments by major
  security type, as of December 31, 1994, are as follows:

                                                            Gross      Gross
                                     Market       Cost Unrealized  Unrealized
  (In thousands)                      Value      Basis       Gains     Losses
  ---------------------------------------------------------------------------
  Government agency securities     $287,418   $291,342    $      -   $  3,924
  Corporate bonds                   298,799    301,103          74      2,378
  Tax-exempt securities              33,588     33,882           -        294
  Other                              57,561     56,728       2,783      1,950
                                   --------   --------    --------   --------
                                   $677,366   $683,055    $  2,857   $  8,546
                                   ========   ========    ========   ========

       Short- and long-term available-for-sale investments in the
  accompanying 1994 balance sheet include $348,613,000 with contractual
  maturities of one year or less, $289,293,000 with contractual maturities of
  more than one year through five years, and $39,460,000 with contractual
  maturities of more than five years. Actual maturities may differ from
  contractual maturities as a result of the Company's intent to sell these
  securities prior to maturity and as a result of put and call options that
  enable either the Company and/or the issuer to redeem these securities at
  an earlier date.


                                      16PAGE
<PAGE>
  Thermo Electron Corporation


       The cost of available-for-sale investments that were sold was based on
  specific identification in determining realized gains and losses recorded
  in the accompanying statement of income. Gain on sale of investments in
  1994 resulted from gross realized gains of $6,666,000 and gross realized
  losses of $1,815,000 relating to the sale of available-for-sale
  investments.


  3.  Acquisitions

  In 1994 and 1993, the Company's majority-owned subsidiaries made several
  acquisitions for $174.3 million and $143.8 million in cash, respectively.
       These acquisitions have been accounted for using the purchase method
  of accounting, and the acquired companies' results of operations have been
  included in the accompanying financial statements from their respective
  dates of acquisition. The aggregate cost of these acquisitions exceeded the
  estimated fair value of the acquired net assets by $232 million, which is
  being amortized principally over 40 years. Allocation of the purchase price
  for these acquisitions was based on estimates of the fair value of the net
  assets acquired and, for acquisitions completed in fiscal 1994, is subject
  to adjustment. Pro forma data is not presented since the acquisitions were
  not material to the Company's results of operations.
       "Other accrued expenses" in the accompanying balance sheet includes
  approximately $26 million and $41 million at year-end 1994 and 1993,
  respectively, for estimated severance, relocation, and other reserves
  associated with acquisitions.


  4.  Common Stock

  In 1993, the Company sold 10,125,000 shares of its common stock in a public
  offering for net proceeds of $246.0 million.
       At December 31, 1994, the Company had reserved 35,181,249 unissued
  shares of its common stock for possible issuance under stock-based
  compensation plans, for possible conversion of the Company's convertible
  debentures, and for possible exchange of subsidiaries' convertible
  obligations into common stock of the Company. The subsidiaries' obligations
  are convertible into common stock of the Company in the event of a change
  in control, as defined in the related fiscal agency agreement, that has not
  been approved by the Company's Board of Directors (Note 6). The conversion
  price would be equal to 50% of the price of the Company's common stock
  prior to the change in control.


  5.  Stock-based Compensation Plans

  The Company has several stock-based compensation plans for its key
  employees, directors, and others, which permit the award of stock-based
  incentives in the stock of the Company and its majority-owned subsidiaries.
  The Company has a nonqualified stock option plan, adopted in 1974, and an
  incentive stock option plan, adopted in 1981, which permit the award of
  stock options to key employees. The incentive stock option plan expired in
  1991 and no grants were made after that date. An equity incentive plan,
  adopted in 1989, permits the grant of a variety of stock and stock-based
  awards as determined by the human resources committee of the Company's
  Board of Directors (the Board Committee), including restricted stock, stock
  options, stock bonus shares or performance-based shares. To date, only
  nonqualified stock options have been awarded under this plan. The option

                                      17PAGE
<PAGE>
  Thermo Electron Corporation


  recipients and the terms of options granted under these plans are
  determined by the Board Committee. Generally, options presently outstanding
  under these plans are exercisable immediately, but are subject to certain
  transfer restrictions and the right of the Company to repurchase shares
  issued upon exercise of the options at the exercise price, upon certain
  events. The restrictions and repurchase rights generally lapse ratably over
  periods ranging from three to ten years after the first anniversary of the
  grant date, depending on the term of the option, which may range from five
  to twelve years. In addition, under certain options, shares acquired upon
  exercise are restricted from resale until retirement or other events.
  Nonqualified options may be granted at any price determined by the Board
  Committee, while incentive stock options must be granted at not less than
  fair market value of the Company's stock on the date of grant. Generally,
  stock options have been granted at fair market value. The Company also has
  a directors' stock option plan, adopted in 1993, that provides for the
  annual grant of stock options of the Company and its majority-owned
  subsidiaries to nonemployee directors pursuant to a formula approved by the
  Company's shareholders. Options awarded under this plan are exercisable six
  months after the date of grant and expire three or seven years after the
  date of grant. In addition to the Company's stock-based compensation plans,
  certain officers and key employees may also participate in stock-based
  compensation plans of the Company's majority-owned subsidiaries.

       No accounting recognition is given to options granted at fair market
  value until they are exercised. Upon exercise, net proceeds, including tax
  benefits realized, are credited to equity.

       A summary of the Company's stock option information is as follows:

                                1994             1993              1992
                          ---------------- ----------------  ---------------
                                    Range             Range            Range
                                       of                of               of
                                   Option            Option           Option
                          Number   Prices  Number    Prices  Number   Prices
  (In thousands except        of      per      of       per      of      per
  per share amounts)      Shares    Share  Shares     Share  Shares    Share
  --------------------------------------------------------------------------
  Options outstanding,            $ 4.85-           $ 4.85-          $ 4.85-
   beginning of year      4,442   $28.21   3,111    $20.87   2,948   $19.35

                                   25.79-            26.15-           
    Granted               1,094    30.07   1,838     28.21     951    20.87

                                    6.15-             4.85-            4.85-
    Exercised              (210)   20.87    (476)    19.35    (720)   17.17

                                    7.69-             7.15-            7.15-
    Lapsed or canceled      (74)   27.59     (31)    24.71     (68)   20.87
                          -----            -----             -----
  Options outstanding,            $ 4.85-           $ 4.85-          $ 4.85-
   end of year            5,252   $30.07   4,442    $28.21   3,111   $20.87
                          =====            =====             =====    
                                  $ 4.85-           $ 4.85-          $ 4.85-
  Options exercisable     5,252   $30.07   4,442    $28.21   3,101   $20.87
                          =====            =====             =====    
  Options available
   for grant              2,418              438             1,793
                          =====            =====             =====
                                      18PAGE
<PAGE>
  Thermo Electron Corporation


  6.  Long-term Obligations and Other Financing Arrangements

  Long-term obligations of the Company are as follows:

  (In thousands except per share amounts)                 1994         1993
  -------------------------------------------------------------------------
  5% Senior convertible debentures,
   due 2001, convertible at $31.50 per share        $  345,000  $        -
  4 5/8% Senior convertible debentures,
   due 1997, convertible at $21.50 per share           205,000     205,000
  4 7/8% Subordinated convertible debentures,
   due 1997, convertible at $21.50 per share            55,000      55,000
  6 3/4% Subordinated convertible debentures,
   due 2001, convertible at $15.33 per share                 -      67,173
  3 3/4% Senior convertible debentures,
   due 2000, convertible into shares of
   Thermo Instrument at $21.17 per share                70,000      70,000
  6 5/8% Subordinated convertible debentures,
   due 2001, convertible into shares of
   Thermo Instrument at $11.72 per share                36,862      49,569
  6 1/2% Subordinated convertible debentures,
   due 1998, convertible into shares of
   Thermedics at $10.42 per share                       10,252      12,997
  6 1/2% Subordinated convertible debentures,
   due 1997, convertible into shares of
   Thermo Process at $10.33 per share                   16,597      18,547
  Noninterest-bearing subordinated convertible
   debentures, due 1997, convertible into shares
   of Thermo Cardiosystems at $21.74 per share          33,000           -
  5 1/2% Subordinated convertible notes,
   due 2002, convertible into shares of
   Thermo Cardiosystems at $9.88 per share                 450         600
  3 3/4% Subordinated convertible debentures,
   due 2000, convertible into shares of Thermo
   Voltek at $11.75 per share                           34,500      34,500
  8.1% Nonrecourse tax-exempt obligation, payable
   in semi-annual installments commencing 1995,
   with final payment in 2000                           62,500      62,500
  6.0% Nonrecourse tax-exempt obligation, payable
   in semi-annual installments, with final
   payment in 2000                                      49,700      57,500
  Tax-exempt obligations, payable in semi-annual
   installments commencing 1995, with final 
   payment in 2017                                     133,670           -
  10.23% Mortgage loan secured by property with a
   net book value of $16,564, payable in monthly
   installments, with a final payment in 2004           10,855      11,535
  Other                                                  8,498      21,558
                                                    ----------  ----------
                                                     1,071,884     666,479
  Less: Current maturities of long-term
   obligations                                          22,034      18,887
                                                    ----------  ----------
                                                    $1,049,850  $  647,592
                                                    ==========  ==========




                                      19PAGE
<PAGE>
  Thermo Electron Corporation


       The debentures that are convertible into subsidiary common stock have
  been issued by the respective subsidiaries and are guaranteed by the
  Company.
        In the event of a change in control of the Company, as defined in the
  related fiscal agency agreement, that has not been approved by the
  Company's Board of Directors, each holder of the 5%, 4 5/8%, and 4 7/8%
  convertible debentures issued by the Company will have the right to require
  the Company to buy all or part of the holders' debentures, at par value
  plus accrued interest, within 50 calendar days after the date of expiration
  of a specified approval period. In addition, the obligations convertible
  into subsidiary common stock become convertible into common stock of the
  Company at a conversion price equal to 50% of the price of the Company's
  common stock prior to the change in control.
       "Nonrecourse tax-exempt obligations" represent obligations issued by
  the California Pollution Control Financing Authority (CPCFA), the proceeds
  of which were used to finance two alternative-energy facilities (Delano I
  and Delano II) located in Delano, California. Delano I was previously
  leased to a subsidiary of Thermo Ecotek by a third-party owner/lessor and
  was purchased by Thermo Ecotek in 1993. Construction of Delano II was
  completed in 1993. The obligations are payable only by a subsidiary of
  Thermo Ecotek and are not guaranteed by the Company, except under limited
  circumstances. As required by the financing bank group, Thermo Ecotek
  entered into interest rate swap agreements that effectively convert these
  obligations from floating rates to the fixed rates described above. These
  swaps have terms expiring in 2000, commensurate with the final maturity of
  the debt. The interest rate swap agreements are with a different
  counterparty than the holders of the underlying debt. The Company believes,
  however, that the credit risks associated with these swaps are minimal
  since the agreements are with a large, reputable bank. The notional amount
  of debt subject to the swap agreements is $110.0 million at December 31,
  1994.
       "Tax-exempt obligations" represent obligations issued by the CPCFA in
  January 1992, the proceeds of which were loaned to the Company to finance
  the construction of a waste-recycling facility in San Diego County,
  California. Construction of this facility was completed in 1994 and the
  debt was reclassified from "Liabilities related to projects under
  construction" to "Long-term obligations" in the accompanying balance sheet.
  Of these tax-exempt obligations, $95 million carry fixed rates of interest
  ranging from 6.75% to 8.2%, and $39 million carry a floating rate of
  interest, which varies weekly based on short-term, tax-exempt markets. The
  interest rate ranged from 3.1% to 7.2% in 1994 and 4.25% to 6.85% in 1993.
       "Tax-exempt obligations" in the accompanying 1993 balance sheet also  
  includes $8.5 million of tax-exempt obligations issued by the CPCFA in
  October 1991, the proceeds of which were loaned to the Company to finance
  the construction of the Delano II alternative-energy facility. These
  tax-exempt obligations were repaid in February 1994. Prior to the
  repayment, these obligations carried a floating rate of interest, which
  varied daily based on short-term, tax-exempt markets. The interest rate
  ranged from 2.45% to 5.55% in 1994 and 2.5% to 6.1% in 1993.
       The Company capitalized interest expense, net of interest income,
  incurred in connection with the construction of the Delano II and San Diego
  County facilities discussed above. These amounts were $2.1 million and $8.4
  million in 1994 and 1993, respectively.





                                      20PAGE
<PAGE>
  Thermo Electron Corporation


       The annual requirements for long-term obligations are as follows:

  (In thousands)
  --------------------------------------------------------
  1995                                          $   22,034
  1996                                              21,773
  1997                                             333,190
  1998                                              36,611
  1999                                              26,597
  2000 and thereafter                              631,679
                                                ----------
                                                $1,071,884
                                                ==========

       Certain of the Company's obligations include requirements to maintain
  predetermined financial ratios. At December 31, 1994, the Company was in
  compliance with these requirements.
       Based on quoted market prices and on borrowing rates currently
  available to the Company for debt of the same remaining maturities, the
  fair market value of the Company's long-term obligations, excluding
  interest rate swap agreements, was approximately $1.24 billion and $1.03
  billion at December 31, 1994 and January 1, 1994, respectively. The fair
  market value of interest rate swap agreements entered into in connection
  with the nonrecourse tax-exempt obligations was a net receivable of
  approximately $2.1 million and a net payable of approximately $6.1 million
  at December 31, 1994 and January 1, 1994, respectively. During 1994, the
  average variable rate received under the interest rate swap agreements was
  4.9%.
       "Notes payable and current maturities of long-term obligations" in the
  accompanying balance sheet include $71.9 million and $51.3 million in 1994
  and 1993, respectively, of short-term bank borrowings at several of the
  Company's subsidiaries. The weighted average interest rates for these
  borrowings were 6.2% at both year-end 1994 and 1993.


  7.  Commitments and Contingencies

  Litigation

  The Company participates in the operation of the Dade County Downtown
  Government Center cogeneration facility in Miami, Florida, through a 50/50
  joint venture of subsidiaries of the Company and Rolls-Royce, Inc. Because
  the demand for power and chilled water at the Dade County Downtown
  Government Center complex has been substantially less than anticipated
  since the plant's startup in 1987, and because the plant has had difficulty
  disposing of the rest of its output, the joint venture has experienced
  continuing losses.
      The joint venture sells electricity to Dade County pursuant to an
  energy purchase contract signed in 1983. The joint venture historically has
  sold more than half of its actual output to Dade County and the balance to
  Florida Power and Light (FPL), the local utility. In 1992, the joint
  venture sued Dade County in Florida state court, alleging that Dade County
  was in breach of the energy purchase contract and had misrepresented its
  demand for electrical power. Dade County asserted counterclaims against the
  joint venture, the Company, and Rolls-Royce, alleging, among other things,
  failure to properly maintain and operate the facility and to use its best
  efforts to maximize use of the facility's output. In May 1993, Dade County
  filed a petition with the Florida Public Service Commission (FPSC),

                                      21PAGE
<PAGE>
  Thermo Electron Corporation


  asserting that the joint venture was engaged in the retail sale of
  electricity without complying with rules governing public utilities. If
  FPSC determines that the joint venture was engaged in illegal retail sales
  of electricity, it could impose refund or other liabilities on the joint
  venture and/or enjoin future sales.
      In May 1993, Dade County also brought a parallel proceeding before the
  Federal Energy Regulatory Commission (FERC) seeking to terminate the
  project's qualifying facility status under the Public Utility Regulatory
  Policies Act of 1978 (PURPA) for failure to meet certain required
  efficiency standards at various times from 1987 to the present. (PURPA
  generally obligates utilities, such as FPL, to purchase electricity from
  qualifying facilities at the utilities' avoided cost and exempts qualifying
  facilities from various federal and state regulations, such as the Federal
  Power Act (FPA).) The Company believes the project currently meets the
  efficiency standards and therefore currently has qualifying facility
  status. However, on October 21, 1993, FERC issued an order finding that,
  although the project met the efficiency standards for 1992, the project did
  not meet such standards from 1987 through 1991. FERC denied the joint
  venture's request for a waiver of the efficiency standards for that period
  and also directed the joint venture to show cause why FERC should not find
  that the joint venture was a public utility for FPA purposes during that
  period. If the joint venture is retroactively deemed a public utility under
  FPA, FERC could impose refund liabilities and other penalties to the extent
  FERC does not find either that the joint venture complied with relevant
  FERC regulations or that the regulations should be waived. The joint
  venture has been granted a rehearing of the FERC decision and has asserted
  various grounds for reversal. The joint venture is also entitled to appeal
  FERC's final decision, if necessary. In the rehearing, the County and FPL
  have argued before FERC that the project did not meet the efficiency
  standards for 1992.
      In 1994, the joint venture's lawsuit against Dade County, including
  counterclaims by Dade County, was dismissed with prejudice by agreement of
  the parties. The terms of the dismissal included: (a) payment by Dade
  County, net of amounts paid by the joint venture, of $1,500,000, (b) a
  joint request that FERC terminate its proceedings and vacate its previous
  order, and (c) a joint request that FPSC dismiss the petition brought
  before it by Dade County. FERC has not acted upon the request made to it by
  the joint venture. FPSC granted the request for dismissal. Since the
  settlement with the County, FPL has filed (a) a motion at FERC opposing the
  request made to FERC by the joint venture, and (b) a motion at FPSC,
  similar to one previously filed at FPSC by Dade County, seeking a
  declaration that the joint venture was engaged in the retail sale of
  electricity without complying with the rules governing public utilities.
  The joint venture also is pursuing an antitrust lawsuit against FPL.
      The joint venture leases its generating equipment from Florida Energy
  Partners Limited Partnership (FEP). If the energy purchase contract were to
  be held illegal, FEP could declare a default by the joint venture under the
  lease with FEP, and Dade County could be released from its obligation to
  buy electricity from the joint venture. In the lease, the joint venture
  also covenanted that the project would maintain PURPA qualifying facility
  status. If the joint venture is deemed to have breached this covenant, FEP
  could declare a default under the lease. In the event of a default, among
  other things, FEP could seek to sell or re-lease the equipment and the
  Company generally would be liable for one-half of any deficiency between
  (a) in the event of a sale, approximately $45 million and the amount
  realized from the sale or (b) in the case of re-lease, the present value of
  future rentals and prepayment penalty under the lease (approximately $31


                                      22PAGE
<PAGE>
  Thermo Electron Corporation


  million) and the present value of a fair rental value to be collected from
  a new tenant.
      The joint venture's revenues for the year ended December 31, 1994 and
  the cumulative period from 1987 through 1991 were $3.4 million and $26.3
  million, respectively. The Company reports its interest in the joint
  venture's results of operations using the equity method of accounting.
  Under this method, the Company records 50% of the joint venture's loss, but
  does not report as revenues any of the joint venture's revenues.
      The Company is contingently liable with respect to other lawsuits and
  matters. In the opinion of management, these contingencies will not have a
  material adverse effect on the financial condition of the Company.

  Operating Leases
  The Company leases portions of its office and operating facilities under
  various noncancelable operating lease arrangements. The accompanying
  statement of income includes expenses from operating leases of $24,268,000
  in 1994, $17,233,000 in 1993, and $13,031,000 in 1992. Minimum rental
  commitments under noncancelable operating leases at December 31, 1994, are
  as follows:

  (In thousands)
  -----------------------------------------------------
  1995                                          $22,779
  1996                                           19,233
  1997                                           14,404
  1998                                           10,614
  1999                                            6,416
  2000 and thereafter                            23,203
                                                -------
                                                $96,649
                                                =======

  8.  Employee Benefit Plans

  401(k) Savings Plan
  The Company's 401(k) savings plan covers the majority of the Company's
  eligible full-time U.S. employees. Contributions to the plan are made by
  both the employee and the Company. Company contributions are based on the
  level of employee contributions. For this plan, the Company contributed and
  charged to expense $6,450,000, $4,517,000, and $3,460,000 in 1994, 1993,
  and 1992, respectively.

  Employee Stock Ownership Plan
  The Company's Employee Stock Ownership Plan (ESOP) covers eligible
  full-time U.S. employees. The Company borrowed funds from a financial
  institution and then loaned these funds to the ESOP to purchase shares of
  common stock of the Company and its majority-owned subsidiaries. The loan
  balance between the Company and the financial institution was paid off in
  1992. The loan between the Company and the ESOP is still outstanding. The
  shares purchased are reported as "Deferred compensation" in the
  accompanying balance sheet. The Company makes annual contributions to the
  ESOP and shares are allocated to plan participants based on employee
  compensation. For this plan, the Company charged to expense $1,123,000,
  $1,125,000, and $1,103,000 in 1994, 1993, and 1992, respectively. The 1992
  amount includes interest expense of $228,000.




                                      23PAGE
<PAGE>
  Thermo Electron Corporation


  Employee Stock Purchase Plan
  Substantially all of the Company's full-time U.S. employees are eligible to
  participate in employee stock purchase plans sponsored by the Company or by
  the Company's majority-owned public subsidiaries. Under these plans, shares
  of the Company's common stock may be purchased at the end of a 12-month
  plan year at 85% of the fair market value at the beginning of the plan
  year, and the shares purchased are subject to a one-year resale
  restriction. Shares are purchased through payroll deductions of up to 10%
  of each participating employee's gross wages. Participants of employee
  stock purchase plans sponsored by the Company's majority-owned public
  subsidiaries may also elect to purchase shares of the common stock of the
  subsidiary by which they are employed. During 1994, 1993, and 1992, the
  Company issued 145,836 shares, 187,902 shares, and 127,950 shares of its
  common stock, respectively, under these plans.

  Coleman Research Plans
  Coleman Research has defined contribution pension and 401(k) employee stock
  ownership plans covering eligible employees. For these plans, Coleman
  Research charged to expense $3,601,000, $3,184,000, and $2,224,000 in 1994,
  1993, and 1992, respectively.

  Postretirement Benefits
  Two of the Company's subsidiaries provide postretirement medical benefits
  for employees who meet certain age and length-of-service requirements. As
  of the beginning of fiscal 1992, the Company adopted SFAS No. 106,
  "Accounting for Postretirement Benefits Other Than Pensions," which
  required the Company to change to the accrual method of accounting for
  postretirement medical benefits. 
       The Company elected to recognize the cumulative effect of its
  accumulated postretirement benefit obligation in 1992, which resulted in a
  charge of $1,438,000, net of tax benefits of $844,000. The annual expense
  incurred under SFAS No. 106 and the related obligations required under this
  statement are not material to the Company's financial statements.

  Postemployment Benefits
  The Company provides certain postemployment benefits to former and inactive
  employees. Effective January 2, 1994, the Company adopted SFAS No. 112,
  "Employers' Accounting for Postemployment Benefits." SFAS No. 112 requires
  the recognition of the cost of postemployment benefits if certain criteria
  are met and the amount of benefits can be reasonably estimated. The
  adoption of this statement did not have a material impact on the Company's
  financial statements.


  9.  Income Taxes

  The components of income before income taxes, minority interest, and
  cumulative effect of change in accounting principle are as follows:

  (In thousands)                                   1994      1993      1992
  -------------------------------------------------------------------------
  Domestic                                      $165,761  $113,500  $ 84,548
  Foreign                                         40,615    17,967    18,027
                                                --------  --------  --------
                                                $206,376  $131,467  $102,575
                                                ========  ========  ========



                                      24PAGE
<PAGE>
  Thermo Electron Corporation


       The components of the provision for income taxes are as follows:

  (In thousands)                                   1994      1993      1992
  -------------------------------------------------------------------------
  Currently payable:
   Federal                                      $ 30,089  $ 10,270  $ 12,280
   Foreign                                        16,343     8,643     7,058
   State                                           9,672     5,320     3,923
                                                --------  --------  --------
                                                  56,104    24,233    23,261
                                                --------  --------  --------
  Deferred (prepaid), net:
   Federal                                        11,355     6,922     4,248
   Foreign                                          (243)      931     1,010
   State                                           3,487     1,427      (769)
                                                --------  --------  --------
                                                  14,599     9,280     4,489
                                                --------  --------  --------
                                                $ 70,703  $ 33,513  $ 27,750
                                                ========  ========  ========

       The provision for income taxes that is currently payable does not
  reflect $3,531,000, $3,354,000, and $7,579,000 of tax benefits of the
  Company and its public subsidiaries allocated to "Capital in excess of par
  value" or $112,000, $2,280,000, and $3,137,000 of tax benefits used to
  reduce "Cost in excess of net assets of acquired companies" in 1994, 1993,
  and 1992, respectively.
       The provision for income taxes in the accompanying statement of income
  differs from the provision calculated by applying the statutory federal
  income tax rate of 35% in 1994 and 1993 and 34% in 1992 to income before
  income taxes, minority interest, and cumulative effect of change in
  accounting principle due to the following:

  (In thousands)                                   1994       1993      1992
  --------------------------------------------------------------------------
  Provision for income taxes at statutory rate $ 72,232   $ 46,013  $ 34,876
  Increases (decreases) resulting from:
    Gain on issuance of stock by
     subsidiaries                                (8,849)   (13,770)  (10,272)
    State income taxes, net of federal tax        8,317      4,307     2,081
    Tax-exempt and tax-preferred investment
     income                                        (465)    (1,207)     (251)
    Investment and research and development
     tax credits                                 (2,786)    (6,625)        -
    Foreign tax rate and tax law differential     1,422      3,969     1,916
    Tax benefit of foreign sales corporation     (2,411)    (1,366)     (989)
    Minority interest in partnership losses      (1,454)    (1,057)   (1,157)
    Amortization of cost in excess of net
     assets of acquired companies                 3,450      3,400     1,674
    Nondeductible expenses                        1,121      1,055       238
    Other, net                                      126     (1,206)     (366)
                                               --------   --------  --------
                                               $ 70,703   $ 33,513  $ 27,750
                                               ========   ========  ========






                                      25PAGE
<PAGE>
  Thermo Electron Corporation


       Deferred and short- and long-term prepaid income taxes in the
  accompanying balance sheet consist of the following:

  (In thousands)                                   1994       1993
  ----------------------------------------------------------------
  Deferred income taxes:
   Depreciation                                $ 49,313   $ 38,459
   Intangible assets                              7,373      8,214
   Other                                          1,564      2,065
                                               --------   --------
                                               $ 58,250   $ 48,738
                                               ========   ========
  Prepaid income taxes:
   Other reserves and accruals                 $ 31,369   $ 26,593
   Inventory basis difference                    16,756     10,801
   Capitalized costs and joint venture equity     3,727      7,071
   Accrued compensation                           8,599      7,653
   Allowance for doubtful accounts                5,470      4,108
   Net operating loss carryforwards               6,182      5,200
   Federal tax credit carryforwards               7,869      3,193
   Available-for-sale investments                 1,025          -
   Other, net                                     6,185      7,270
                                               --------   --------
                                                 87,182     71,889
   Less: Valuation allowance                     29,358     20,402
                                               --------   --------
                                               $ 57,824   $ 51,487
                                               ========   ========

       The valuation allowance relates to the uncertainty surrounding the
  realization of tax loss and credit carryforwards and the realization of tax
  benefits attributable to purchase accounting reserves and certain other tax
  assets of the Company and certain subsidiaries. Of the year-end 1994
  valuation allowance, $8.6 million will be used to reduce "Cost in excess of
  net assets of acquired companies" when any portion of the related deferred
  tax asset is recognized and $7.5 million will increase "Capital in excess
  of par value" when previously unrealized stock option benefits are
  recognized.
       The increase in the valuation allowance is primarily attributable to
  the establishment of valuation allowances for tax loss and credit
  carryforwards, net of utilization of previously unbenefited tax attributes.
       The Company has not recognized a deferred tax liability for the
  undistributed earnings of its domestic subsidiaries because the Company
  does not expect these earnings to be remitted and become subject to tax.
  The Company believes it can implement certain tax strategies to recover its
  share of all undistributed earnings of its domestic subsidiaries tax-free.
       A provision has not been made for U.S. or additional foreign taxes on
  $109 million of undistributed earnings of foreign subsidiaries that could
  be subject to taxation if remitted to the U.S. because the Company plans to
  keep these amounts permanently reinvested overseas. The Company believes
  that any additional U.S. tax liability due upon remittance of such earnings
  would be immaterial due to available U.S. foreign tax credits.







                                      26PAGE
<PAGE>
  Thermo Electron Corporation


  10.  Transactions in Stock of Subsidiaries

  "Gain on issuance of stock by subsidiaries" in the accompanying statement
  of income results primarily from the following transactions:

  1994
  ----
       Public offering of 1,610,000 shares of ThermoTrex common stock at
  $15.375 per share for net proceeds of $23,034,000 resulted in a gain of
  $7,906,000.
       Initial public offering of 5,349,572 shares of ThermoLase common stock
  at $3.00 per share for net proceeds of $14,784,000 resulted in a gain of
  $8,609,000.
       Private placements of 1,505,000 shares of ThermoSpectra common stock
  at $10.00 per share for net proceeds of $13,993,000 resulted in a gain of
  $6,469,000.
       Conversion of $3,725,000 of Thermedics 6 1/2% subordinated convertible
  debentures convertible at $10.42 per share into 357,597 shares of
  Thermedics common stock resulted in a gain of $992,000.

  1993
  ----
       Public offering of 3,225,000 shares of Thermedics common stock at
  $10.00 per share for net proceeds of $29,980,000 resulted in a gain of
  $10,707,000.
       Public offering of 4,312,500 shares of Thermo Power common stock at
  $9.00 per share for net proceeds of $35,998,000 resulted in a gain of
  $10,578,000.
       Private placements of 2,062,500 shares of ThermoTrex common stock at
  $11.17 and $14.50 per share for net proceeds of $27,463,000 resulted in a
  gain of $11,400,000.
       Private placement of 300,000 shares and initial public offering of
  1,650,000 shares of Thermo Remediation common stock at $6.59 and $8.33 per
  share, respectively, for net proceeds of $14,554,000 resulted in a gain of
  $4,239,000.
       Conversion of $7,270,000 of Thermedics 6 1/2% subordinated convertible
  debentures convertible at $10.42 per share into 697,919 shares of
  Thermedics common stock resulted in a gain of $2,506,000.

  1992
  ----
       Private placement of 2,709,356 shares and initial public offering of
  3,000,000 shares of Thermo Fibertek common stock at $6.70 to $8.00 per
  share for net proceeds of $39,748,000 resulted in a gain of $23,303,000.
       Issuance of 1,566,480 restricted shares of ThermoTrex common stock
  valued at $6.17 per share, or $9,673,000, to acquire Lorad Corporation
  resulted in a gain of $3,081,000.
       Private placement of 375,000 shares of ThermoTrex common stock at
  $10.67 per share for net proceeds of $3,556,000 resulted in a gain of
  $1,745,000.

       The Company's ownership percentage in these subsidiaries changed
  primarily as a result of the transactions listed above, as well as the
  Company's purchases of shares of its majority-owned subsidiaries' stock,
  the subsidiaries' purchases of their own stock, the issuance of
  subsidiaries' stock by the Company or by the subsidiaries under stock-based
  compensation plans or in other transactions, and the conversion of


                                      27PAGE
<PAGE>
  Thermo Electron Corporation


  convertible obligations held by the Company, its subsidiaries, or by third
  parties.

       The Company's ownership percentages at year-end were as follows:

                                     1994        1993         1992
                                     ----        ----         ----
  Thermedics                         51%          52%          59%
  Thermo Instrument                  83%          81%          81%
  Thermo Process                     80%          72%          71%
  Thermo Power                       60%          52%          81%
  ThermoTrex                         50%          55%          62%
  Thermo Fibertek                    81%          80%          80%
  Thermo Ecotek (Note 15)            97%          88%          87%
  Thermo Cardiosystems (a)           58%          57%          58%
  Thermo Voltek (a)                  71%          67%          57%
  Thermo Remediation (b)             65%          67%          85%
  ThermoLase (c)                     69%          81%         100%
  ThermoSpectra (d)                  86%         100%         100%

  (a) Reflects combined ownership by Thermo Electron and Thermedics.
  (b) Reflects ownership by Thermo Process.
  (c) Reflects ownership by ThermoTrex.
  (d) Reflects ownership by Thermo Instrument.


  11.  Other Income (Expense), Net

  The components of "Other income (expense), net" in the accompanying
  statement of income are as follows:

  (In thousands)                               1994        1993        1992
  -------------------------------------------------------------------------
  Interest income                          $ 43,280    $ 23,905    $ 24,728
  Interest expense                          (59,844)    (31,736)    (24,322)
  Equity in losses of unconsolidated
   subsidiaries                              (4,019)    (22,721)     (3,948)
  Gain on sale of investments                 4,851       2,469       4,968
  Other income, net                          14,743         535         416
                                           --------    --------    --------
                                           $   (989)   $(27,548)   $  1,842
                                           ========    ========    ========


  12.  Costs Associated with Divisional and Product Restructuring

  "Costs associated with divisional and product restructuring" in the
  accompanying 1994 statement of income represents severance costs and, to a
  lesser extent, the costs to write-off leasehold improvements at
  ThermoTrex's East Coast division.
       The 1993 amount primarily represents a $1,900,000 reserve for the
  write-off of machinery and equipment and costs to phase out a product line
  in the Company's metal-fabrication services business, a $1,200,000 reserve
  for restructuring at the Company's steam turbines and compressors business,
  and $2,660,000 for the write-off of mobile soil-remediation assets and
  other related expenses.



                                      28PAGE
<PAGE>
  Thermo Electron Corporation


  13.  Supplemental Cash Flow Information

  Supplemental cash flow information is as follows:

  (In thousands)                                1994        1993        1992
  --------------------------------------------------------------------------
  Cash Paid For:
   Interest                                $  47,745   $  29,529   $  18,313
   Income taxes                            $  27,456   $   9,909   $  16,751

  Noncash Activities:
   Conversions of convertible obligations  $  89,625   $  50,403   $  13,863
   Purchase of alternative-energy
    facility through assumption of debt    $       -   $  66,900   $       -

   Fair value of assets of acquired
    companies                              $ 250,404   $ 208,193   $ 429,113
   Cash paid for acquired companies         (174,330)   (143,790)   (255,340)
   Issuance of subsidiary common stock
    for acquired business                          -           -      (9,673)
                                           ---------   ---------   ---------
     Liabilities assumed of acquired
      companies                            $  76,074   $  64,403   $ 164,100
                                           =========   =========   =========


  14.  Business Segment and Geographical Information

  The Company's business segments include the following:
    Instruments: environmental-monitoring, analytical, and process-control
    instruments
    Alternative-energy Systems: alternative-energy power plants,
    waste-recycling facility, industrial refrigeration systems, natural gas
    engines, cooling and cogeneration units, turbines and compressors
    Process Equipment: paper-recycling equipment, papermaking systems and
    accessories, metallurgical processing systems, electroplating equipment
    Biomedical Products: biomedical materials, mammography and needle-biopsy
    systems, skin-incision devices, blood coagulation-monitoring equipment,
    left ventricular-assist systems, neurophysiology monitoring instruments,
    personal-care products
    Environmental Services: thermal soil-remediation, industrial-fluids
    recycling, metallurgical heat treating and fabrication, laboratory
    analysis, environmental sciences
    Advanced Technologies: process detection systems, security instruments,
    electronic test equipment, power-conversion instruments, long-term hair
    removal system, development of avionics products and medical systems













                                      29PAGE
<PAGE>
  Thermo Electron Corporation


  (In thousands)                             1994          1993         1992
  --------------------------------------------------------------------------
  Revenues:
   Instruments                         $  650,114    $  516,712   $  349,261
   Alternative-energy Systems             285,410       242,662      221,877
   Process Equipment                      189,862       167,524      160,459
   Biomedical Products                    180,318       127,533       58,167
   Environmental Services                 141,793       121,987      114,268
   Advanced Technologies                  286,523       181,094       96,331
   Intersegment Sales Elimination (a)      (4,829)       (3,004)      (1,135)
                                       ----------    ----------   ----------
                                       $1,729,191    $1,354,508   $  999,228
                                       ==========    ==========   ==========
  Segment Income (b):
   Instruments                         $  105,440    $   91,412   $   59,758
   Alternative-energy Systems              34,451        14,434        1,767
   Process Equipment                       20,730        13,924       13,891
   Biomedical Products                     17,601         5,758        1,252
   Environmental Services                  14,853         9,263        8,411
   Advanced Technologies                   13,213         8,260        2,516
                                       ----------    ----------   ----------
    Total Segment Income                  206,288       143,051       87,595
   Equity in Losses of Unconsolidated
    Subsidiaries                           (4,019)      (22,721)      (3,948)
   Corporate (c)                            4,107        11,137       18,928
                                       ----------    ----------   ----------
   Income Before Income Taxes,
    Minority Interest, and Cumulative
    Effect of Change in Accounting
    Principle                          $  206,376    $  131,467   $  102,575
                                       ==========    ==========   ==========
  Identifiable Assets:
   Instruments                         $1,011,916    $  850,688   $  531,320
   Alternative-energy Systems             577,781       593,247      406,515
   Process Equipment                      191,846       179,251      172,984
   Biomedical Products                    348,199       285,715      228,781
   Environmental Services                 192,523       146,658      129,656
   Advanced Technologies                  236,543       203,375      101,127
   Corporate (d)                          503,127       248,663      267,600
                                       ----------    ----------   ----------
                                       $3,061,935    $2,507,597   $1,837,983
                                       ==========    ==========   ==========

















                                      30PAGE
<PAGE>
  Thermo Electron Corporation


  (In thousands)                             1994          1993         1992
  --------------------------------------------------------------------------
  Depreciation and Amortization:
   Instruments                         $   22,070    $   18,059   $   10,786
   Alternative-energy Systems              16,078         4,982        3,511
   Process Equipment                        4,780         4,277        3,792
   Biomedical Products                      6,292         5,328        2,922
   Environmental Services                   8,382         6,641        5,845
   Advanced Technologies                    6,193         3,679        2,512
   Corporate                                1,233         1,226        1,095
                                       ----------    ----------   ----------
                                       $   65,028    $   44,192   $   30,463
                                       ==========    ==========   ==========
  Capital Expenditures:
   Instruments                         $    7,574    $    6,347   $    4,650
   Alternative-energy Systems (e)          31,717        92,862       38,097
   Process Equipment                        3,231         2,631        3,721
   Biomedical Products                      7,284         9,042        2,245
   Environmental Services                   7,559         7,583        8,550
   Advanced Technologies                    8,019         8,898        4,994
   Corporate                                  141         2,241        1,063
                                       ----------    ----------   ----------
                                       $   65,525    $  129,604   $   63,320
                                       ==========    ==========   ==========
  Export Sales Included Above (f)      $  265,298    $  219,914   $  131,755
                                       ==========    ==========   ==========
  Foreign Operations Included Above:
    Revenues:
      Europe                           $  295,203    $  223,707   $  198,066
      Other                                61,586        32,835       22,941
                                       ----------    ----------   ----------
                                       $  356,789    $  256,542   $  221,007
                                       ==========    ==========   ==========
    Income Before Income Taxes,
     Minority Interest, and Cumulative
     Effect of Change in Accounting
     Principle:
      Europe                           $   30,490    $   11,305   $   17,627
      Other                                10,125         6,662          400
                                       ----------    ----------   ----------
                                       $   40,615    $   17,967   $   18,027
                                       ==========    ==========   ==========
    Identifiable Assets:
      Europe                           $  386,645    $  299,091   $  239,431
      Other                                60,697        41,068       36,877
                                       ----------    ----------   ----------
                                       $  447,342    $  340,159   $  276,308
                                       ==========    ==========   ==========

  (a)  Intersegment sales are accounted for at prices that are representative
       of transactions with unaffiliated parties.
  (b)  Segment income is income before corporate general and administrative
       expenses, costs associated with divisional and product restructuring,
       other income and expense, minority interest expense, and income taxes.
  (c)  Includes corporate general and administrative expenses, costs
       associated with divisional and product restructuring, other income and
       expense, and gain on issuance of stock by subsidiaries.


                                      31PAGE
<PAGE>
  Thermo Electron Corporation

  (d)  Primarily cash and cash equivalents, short- and long-term investments,
       and property and equipment at the Company's Waltham, Massachusetts,
       headquarters.
  (e)  Includes $88.4 million in 1993 for the purchase of an alternative-
       energy facility in Delano, California, and $30.5 million in 1992 for
       the purchase of an alternative-energy facility in Whitefield, New
       Hampshire.
  (f)  In general, export revenues are denominated in U.S. dollars.

  15.  Subsequent Event

  Acquisitions
  On March 15, 1995, the Company acquired Coleman Research Corporation
  (Coleman Research) in exchange for 4,002,224 shares of Company common
  stock, including 202,861 shares reserved for issuance upon exercise of
  stock options. Coleman Research provides systems integration, systems
  engineering, and analytical services to government customers in the fields
  of information technology, energy and the environment, software
  engineering, launch systems, advance radar and imaging, and healthcare
  systems. The acquisition has been accounted for under the
  pooling-of-interests method.
       Accordingly, all historical financial information presented has been
  restated to include the acquisition of Coleman Research. Revenues and net
  income for 1994 and 1993, as previously reported by the separate entities
  prior to the acquisition and as restated for the combined Company, are as
  follows:

  (In thousands)                              1994         1993         1992
  --------------------------------------------------------------------------
  Revenues:
   Previously reported                  $1,585,348   $1,249,718   $  948,972
   Coleman Research                        143,843      104,790       50,256
                                        ----------   ----------   ----------
                                        $1,729,191   $1,354,508   $  999,228
                                        ==========   ==========   ==========

  Net Income:
   Previously reported                  $  103,410   $   76,633   $   59,156
   Coleman Research                          1,301          235          329
                                        ----------   ----------   ----------
                                        $  104,711   $   76,868   $   59,485
                                        ==========   ==========   ==========

       On March 1, 1995, the Company's Thermo Instrument subsidiary entered
  into an agreement to acquire the Scientific Instruments Division (the
  Division) of Fisons plc for approximately 202 million British pounds
  sterling, subject to a post-closing adjustment based on the net asset value
  of the Division as of the closing date. The Division is principally
  composed of operations that are involved in the research, development,
  manufacture, and sale of analytical instruments to industrial and research
  laboratories worldwide. For the fiscal year ended December 31, 1994, the
  Division had unaudited revenues of approximately 262 million British pounds
  sterling and an unaudited net loss of approximately 19 million British
  pounds sterling.
       On April 13, 1995, Thermo Instrument announced that it had received a
  "second request" for information regarding the transaction from the U.S.
  Federal Trade Commission (FTC). The FTC and other national regulatory
  competition authorities have expressed concern that completion of the
  transaction in its original form would affect competition in markets for

                                      32PAGE
<PAGE>
  Thermo Electron Corporation


  certain product lines to be acquired by Thermo Instrument. On June 30,
  1995, Thermo Instrument and Fisons plc agreed to extend the termination
  date under the agreement from June 30, 1995 to August 15, 1995 to allow for
  the negotiation of potential modifications to the transaction. In addition
  to receipt of required antitrust regulatory approvals, completion of the
  transaction is subject to consent of certain third parties, and the
  satisfaction of other customary closing conditions.

  Stock Split
  All weighted average share and per share amounts have been restated to
  reflect a three-for-two stock split, effected in the form of a 50% stock
  dividend, that was distributed in May 1995. 















































                                      33PAGE
<PAGE>
   Report of Independent Public Accountants

   To the Shareholders and Board of Directors
   of Thermo Electron Corporation:

        We have audited the accompanying consolidated balance sheet of Thermo
   Electron Corporation (a Delaware corporation) and subsidiaries as of
   December 31, 1994 and January 1, 1994, and the related consolidated
   statements of income, shareholders' investment, and cash flows for each of
   the three years in the period ended December 31, 1994. These consolidated
   financial statements are the responsibility of the Company's management.
   Our responsibility is to express an opinion on these consolidated financial
   statements based on our audits.
        We conducted our audits in accordance with generally accepted auditing
   standards. Those standards require that we plan and perform the audit to
   obtain reasonable assurance about whether the financial statements are free
   of material misstatement. An audit includes examining, on a test basis,
   evidence supporting the amounts and disclosures in the financial
   statements. An audit also includes assessing the accounting principles used
   and significant estimates made by management, as well as evaluating the
   overall financial statement presentation. We believe that our audits
   provide a reasonable basis for our opinion.
        In our opinion, the consolidated financial statements referred to
   above present fairly, in all material respects, the financial position of
   Thermo Electron Corporation and subsidiaries as of December 31, 1994 and
   January 1, 1994, and the results of their operations and their cash flows
   for each of the three years in the period ended December 31, 1994, in
   conformity with generally accepted accounting principles.
        As discussed in Note 8 to the consolidated financial statements,
   effective December 29, 1991, the Company changed its method of accounting
   for postretirement benefits other than pensions. Also, as discussed in Note
   2 to the consolidated financial statements, effective January 2, 1994, the
   Company changed its method of accounting for investments in debt and
   marketable equity securities.



                                                Arthur Andersen LLP



   Boston, Massachusetts
   February 10, 1995
   (Except with respect to the matters
   discussed in Note 15 as to which the
   date is July 20, 1995)













                                       34PAGE
<PAGE>
   Thermo Electron Corporation


   Management's Discussion and Analysis of Financial Condition and Results of
   Operations

   Overview

   The Company develops and manufactures a broad range of products that are
   sold worldwide. The Company expands the product lines and services it
   offers by developing and commercializing its own core technologies and by
   making strategic acquisitions of complementary businesses. The majority of
   the Company's businesses fall into four broad markets: environmental,
   energy, process control, and selected health and safety instrumentation.
        An important component of the Company's strategy is to establish
   leading positions in its markets through the application of proprietary
   technology, whether developed internally or acquired. A key contribution to
   the growth of the Company's segment income (as defined in the results of
   operations below), particularly over the last three years, has been the
   ability to identify attractive acquisition opportunities, complete those
   acquisitions, and derive a growing income contribution from the newly
   acquired businesses as they are integrated into the Company's business
   segments.
        The Company seeks to minimize its dependence on any specific product
   or market by maintaining and diversifying its portfolio of businesses and
   technologies. Similarly, the Company's goal is to maintain a balance in its
   businesses between those affected by various regulatory cycles and those
   more dependent on the general level of economic activity. Although the
   Company is diversified in terms of technology, product offerings, and
   geographic markets served, the future financial performance of the Company
   as a whole is largely affected by the strength of worldwide economies and
   the continued adoption and diligent enforcement of environmental
   regulations, among other factors.
        The Company believes that maintaining an entrepreneurial atmosphere is
   essential to its continued growth and development. In order to preserve
   this atmosphere, the Company has adopted a strategy of spinning out certain
   of its businesses into separate subsidiaries and having these subsidiaries
   sell a minority interest to outside investors. The Company believes that
   this strategy provides additional motivation and incentives for the
   management of the subsidiaries through the establishment of subsidiary-
   level stock option incentive programs, as well as capital to support the
   subsidiaries' growth. As a result of the sale of stock by subsidiaries, the
   issuance of stock by subsidiaries upon conversion of convertible
   debentures, and similar transactions, the Company records gains that
   represent the increase in the Company's net investment in the subsidiaries
   and are classified as "Gain on issuance of stock by subsidiaries" in the
   accompanying statement of income. These gains have represented a
   substantial portion of the net income reported by the Company in recent
   years. Although the Company expects to continue this strategy in the
   future, its goal is to continue increasing segment income over the next few
   years so that gains generated by the sale of stock by its subsidiaries will
   represent a decreasing portion of total net income. The size and timing of
   these transactions are dependent on market and other conditions that are
   beyond the Company's control. Accordingly, there can be no assurance that
   the Company will be able to generate gains from such transactions in the
   future.






                                       35PAGE
<PAGE>
   Thermo Electron Corporation

   Results of Operations

   1994 Compared With 1993
   -----------------------

        Sales in 1994 were $1,729.2 million, an increase of $374.7 million, or
   28%, over 1993. Segment income was $206.3 million, compared with $143.1
   million in 1993, an increase of 44%. (Segment income is income before
   corporate general and administrative expenses, costs associated with
   divisional and product restructuring, other income and expense, minority
   interest expense, and income taxes.) Operating income was $182.1 million,
   compared with $119.2 million in 1993, an increase of 53%.
        Sales from the Instruments segment were $650.1 million in 1994, an
   increase of $133.4 million, or 26%, over 1993. Sales increased due to
   acquisitions made by Thermo Instrument during 1993 and its acquisition of
   several businesses within the EnviroTech Measurements & Controls group of
   Baker Hughes Incorporated in March 1994. Segment income margin (segment
   income margin is segment income as a percentage of sales) was 16.2%,
   compared with 17.7% in 1993. Segment income margin declined principally due
   to lower margins at the acquired businesses within the EnviroTech
   Measurements & Controls group.
        Sales from the Alternative-energy Systems segment were $285.4 million,
   an increase of $42.7 million, or 18%, over 1993. Within this segment,
   revenues from Thermo Ecotek (formerly Thermo Energy Systems), which consist
   of revenues from alternative-energy power plant operations, were $134.3
   million, compared with $117.7 million in 1993. This increase results from
   an additional plant in operation in 1994 and, to a lesser extent, the
   absence of utility-imposed curtailments of power output as well as improved
   performance at two California plants and annual contractual energy rate
   increases under certain power sales contracts. The 1993 period included
   $9.8 million of revenues recorded as a result of the termination of a power
   sales contract, and $3.1 million from the one-time sale of gas pipeline
   rights. Sales from the Company's wholly owned Energy Systems division
   increased $10.7 million as a result of a waste-recycling facility in San
   Diego County that commenced operations in the first quarter of 1994. Sales
   from Thermo Power increased 19%, to $91.9 million, as a result of the
   inclusion of $8.4 million in sales from its NuTemp, Inc. subsidiary, which
   was acquired in May 1994, and due to increased demand for refrigeration
   packages at its FES division.
        Segment income from the Alternative-energy Systems segment was $34.5
   million, compared with $14.4 million in 1993. Thermo Ecotek had segment
   income of $26.9 million, compared with $13.2 million in 1993. This
   improvement results from an additional power plant in operation during
   1994, the absence of utility-imposed curtailments of power output and
   improved performance at two California plants, and annual contractual
   energy rate increases under certain power sales contracts. The utility that
   purchases the output of two of the Company's California plants has the
   right to curtail the plants' power output up to 1,000 hours per year during
   periods of low demand. The utility commonly experiences low demand
   following periods of heavy rain or snow, when hydroelectric power is
   available. Due to abnormally heavy rainfall during January 1995, utility
   curtailment of two of the Company's California plants is likely to reach
   the contractually allowable maximum of 1000 hours at each of the plants in
   1995. Thermo Ecotek's segment income also improved as a result of lower
   lease expense, offset in part by depreciation expense, resulting from the
   December 1993 purchase of the Delano I facility in California. The 1993
   period included $8.6 million of income from the termination of a power
   sales contract and the one-time sale of gas pipeline rights. Segment income
   from the Company's Energy Systems division increased $3.4 million as a

                                       36PAGE
<PAGE>
   Thermo Electron Corporation


   result of the waste-recycling facility that commenced operation in the
   first quarter of 1994. Segment income increased at Thermo Power by $2.6
   million as a result of increased sales, as well as lower expenses at its
   Crusader Engines division.
        Certain of Thermo Ecotek's plants have power sales agreements with
   utilities under which the rates paid for power will convert from fixed
   rates to "avoided cost" rates in the year 2000. Avoided cost rates are
   currently substantially less than the fixed rates. Two of these plants have
   conditions in their nonrecourse lease agreements that require funding of
   "power reserves" in years prior to 2000, based on projections of operating
   cash flow shortfalls in the year 2000 and thereafter. The power reserves
   represent funds available to make lease payments in the event that revenues
   are not sufficient after the plants convert to avoided cost rates. Without
   sufficient increases in avoided cost rates or reductions in fuel costs and
   other operating expenses by the year 2000, Thermo Ecotek expects to either
   renegotiate its nonrecourse lease agreements or forfeit its interests in
   the plants. Beginning in 1996, if projected avoided cost rates remain at
   current levels, Thermo Ecotek will expense the funding of reserves required
   under the nonrecourse lease agreements. As a result, the income from the
   two plants is expected to be reduced to approximately break-even beginning
   in 1996. The plants contributed $9.6 million of segment income in 1994.
        Sales in the Process Equipment segment were $189.9 million, compared
   with $167.5 million in 1993. Within this segment, sales from Thermo
   Fibertek increased to $162.6 million from $137.1 million in 1993 due to an
   increase of $17.6 million in sales as a result of the acquisition of AES
   Engineered Systems in June 1993, an increase of $7.9 million in sales from
   the Company's paper-recycling equipment business as a result of three large
   contracts received earlier in the year, and an increase of $4.1 million in
   sales from the Company's U.S. accessories business due to greater demand.
   These increases were offset in part by a decline of $4.4 million in sales
   of environmental process systems sold by the Company's U.K. subsidiary, to
   $1.3 million in 1994, as a result of changes in U.K. environmental
   regulations that required modifications to that subsidiary's equipment.
   Thermo Fibertek intends to exit this business during 1995. In December
   1994, a wholly owned subsidiary of the Company entered into a $145 million
   contract for engineering, procurement, and construction services for an
   office wastepaper de-inking facility to be located in Menominee, Michigan.
   Construction is expected to take place over approximately two years. Thermo
   Fibertek will supply approximately $15 million of equipment and services
   for this project over the next two years. Sales of Holcroft heat-treating
   systems, which remain depressed, declined $1.5 million in 1994, and sales
   of automated electroplating equipment from the Company's wholly owned
   Napco, Inc. subsidiary declined $1.5 million due to weak demand. The
   Process Equipment segment income margin was 10.9%, compared with 8.3% in
   1993. Thermo Fibertek's segment income margin improved to 12.9% from 11.6%
   in 1993, primarily due to increased sales and an improved sales mix.
   Holcroft operations were just above the break-even level while Napco
   operations resulted in a segment loss of $0.3 million due to lower sales
   levels.
        Sales in the Biomedical Products segment were $180.3 million, an
   increase of $52.8 million, or 41%, over 1993. Sales increased $18.1 million
   due to the inclusion for a full year of sales from CBI Laboratories, Inc.,
   which was acquired by the Company's ThermoLase subsidiary in December 1993.
   Sales of a number of the Company's biomedical products also contributed to
   the increase, including ThermoTrex's mammography and needle-biopsy systems,
   which increased 45% to $54.4 million; Thermo Cardiosystems' implantable
   left ventricular-assist systems, which increased $6.9 million; blood
   coagulation-monitoring products and skin incision devices sold by the

                                       37PAGE
<PAGE>
   Thermo Electron Corporation


   Company's wholly owned International Technidyne Corporation subsidiary,
   which increased 18% to $28.6 million; and Thermedics' Scent Seal fragrance
   samplers, which increased $3.0 million, due primarily to increased demand.
   Segment income margin improved to 9.8% from 4.5% in 1993 as a result of
   increased sales and efforts to reduce costs.
        Sales in the Environmental Services segment were $141.8 million,
   compared with $122.0 million in 1993. Within this segment, sales from
   Thermo Remediation increased $8.6 million, to $29.7 million, primarily due
   to an increase in the volume of soil processed at its soil-remediation
   centers and, to a lesser extent, the inclusion of revenues from businesses
   acquired during 1994 and late 1993. Sales of analytical laboratory and
   environmental consulting services increased 10.9% to $61.2 million, due to
   the inclusion of sales from businesses acquired during 1994 and, to a
   lesser extent, the addition of a long-term environmental restoration
   contract for the U.S. Department of Energy's Hanford, Washington site.
   Sales of metallurgical services increased 9.1%, to $44.8 million, due to
   increased demand. Segment income margin improved to 10.5% from 7.6% in
   1993, due to increased sales and efforts to reduce costs.
        Sales from the Advanced Technologies segment were $286.5 million,
   compared with $181.1 million in 1993. Sales increased $54.7 million due to
   the inclusion of sales from Ramsey Technology Inc., which was acquired by
   Thermedics in March 1994, and Comtest, which was acquired by Thermo Voltek
   in August 1993. Revenues from Coleman Research's government-sponsored
   research and development contracts increased $39.1 million, while revenues
   from ThermoTrex's government-sponsored research and development contracts
   increased $1.8 million. Sales of Thermedics' EGIS explosives-detection
   systems increased $4.1 million, and sales of Thermedics' process detection
   instruments, principally to one customer, increased $3.6 million. Segment
   income margin was 4.6% in both 1994 and 1993. Improved segment income
   margin at Coleman Research as a result of increased revenues was offset by
   lower margins at ThermoTrex as a result of increased research and
   development expenses to develop and commercialize new products and, to a
   lesser extent, lower margins at newly acquired businesses.
        The Company's wholly owned Napco subsidiary is challenging a jury
   verdict rendered against it during the third quarter of 1994 for $12.2
   million plus prejudgement interest in a contract dispute arising out of an
   allegedly defective waste-treatment system installed by Napco in 1984. The
   Company believes the verdict is in error and is vigorously pursuing all
   available post-trial remedies. These remedies include seeking to have the
   verdict set aside or substantially reduced and, if necessary, taking an
   appeal. In the third quarter of 1994, the Company increased its reserve for
   potential losses from pending litigation by approximately $4.0 million,
   which is reflected in Corporate general and administrative expenses.
        As a result of the sale of stock by subsidiaries, the issuance of
   stock by subsidiaries upon conversion of indebtedness, and similar
   transactions, the Company recorded gains of $25.3 million in 1994 and $39.9
   million in 1993. Such gains represent the increase in the Company's
   proportionate share of the subsidiaries' equity and are classified as "Gain
   on issuance of stock by subsidiaries" in the accompanying statement of
   income. See Notes 1 and 10 to Consolidated Financial Statements for a more
   complete description of these transactions. Minority interest expense
   increased to $31.0 million in 1994 from $21.1 million in 1993. Minority
   interest expense includes $5.6 million in 1994 and $1.3 million in 1993
   relating to gains recorded by the Company's majority-owned subsidiaries as
   a result of the sale of stock by their subsidiaries.
        "Other income (expense), net" in the accompanying statement of income
   includes a gain of $14.7 million resulting from the sale of the Peter
   Brotherhood Ltd. facility in the United Kingdom. Peter Brotherhood was

                                       38PAGE
<PAGE>
   Thermo Electron Corporation


   relocated to a new and more efficient facility. Also included is equity in
   losses of unconsolidated subsidiaries, which represents the Company's
   portion of results from entities in which the Company's ownership is 50% or
   less, primarily the operation of the Dade County cogeneration facility,
   and, beginning in 1994, the Company's share of the profit from a 50%-owned
   joint venture that is responsible for the operation and maintenance of the
   Company's waste-recycling facility in San Diego. The loss associated with
   the Dade County facility was $5.2 million in 1994, compared with a loss of
   $5.7 million in 1993, excluding the $15.0 million provision recorded in
   1993.
        Because the demand for power and chilled water at the Dade County
   Downtown Government Center complex has been substantially less than
   anticipated since the plant's startup in 1987, and because the plant has
   had difficulty disposing of the remainder of its output, the joint venture
   continues to experience losses. Although the joint venture pursues
   alternatives to improve the profitability of this plant, such actions to
   date have not been effective, and there is no assurance that this situation
   will improve. In September 1994, the joint venture temporarily suspended
   operation of this plant for an indefinite period of time although it will
   continue to be responsible for lease and other fixed costs. The $15.0
   million reserve established in 1993 represents management's estimate,
   discounted to present value, of the Company's share of estimated future
   negative cash flows of the joint venture. The Company is involved in
   regulatory proceedings that could require additional reserves, if the
   outcome of one or more of these matters is adverse to the Company (see Note
   7 to Consolidated Financial Statements).
        A wholly owned subsidiary of the Company owns a waste-recycling
   facility in southern California that processes waste for San Diego County
   (the County). The subsidiary has contracted the operation and maintenance
   of the facility to a 50%-owned joint venture. In February 1995, the
   subsidiary was notified by the lead financing bank that the County was not
   in compliance with a covenant contained in the financing arrangements for
   the tax-exempt obligations issued in connection with construction of the
   facility. The financing arrangements are nonrecourse to the Company for
   issues relating to County defaults. Were the County to remain out of
   compliance, the bank group could declare a default on the tax-exempt
   obligations and foreclose on the facility. Such a default would result in
   the bank group and the subsidiary having claims against the County for
   damages, however, the County's responsibility to pay these damages could be
   limited to the funds it has available from the day-to-day operation of the
   County's solid waste-disposal system. Accordingly, the ultimate outcome of
   this matter could result in an impairment of the subsidiary's investment in
   the facility. The subsidiary's investment in the facility, including
   unfunded equity commitments of $5.5 million, was approximately $16.5
   million at December 31, 1994.
        In a lawsuit relating to the waste-recycling facility discussed above,
   a third party from whom the Company's subsidiary acquired certain
   development rights alleges that fees totaling $7.9 million plus interest
   and legal costs are due and payable from the subsidiary in connection with
   construction of the facility. The Company contends that no additional fees
   are payable because the facility actually built was substantially different
   from the one contemplated in the agreement with the third party developer.
   A jury trial is expected to commence in 1995. There can be no assurance as
   to the outcome of this matter.





                                       39PAGE
<PAGE>
   Thermo Electron Corporation

   1993 Compared With 1992
   -----------------------

   Sales in 1993 were $1,354.5 million, an increase of $355.3 million, or 36%,
   over 1992. Segment income was $143.1 million, compared with $87.6 million
   in 1992, an increase of 63%. Operating income was $119.2 million, compared
   with $70.5 million in 1993, an increase of 69%.
        Sales from the Instruments segment were $516.7 million, an increase of
   $167.5 million, or 48%, over 1992. Sales increased approximately $153
   million due to additional revenues from acquired businesses, including
   Nicolet Instrument Corporation in August 1992, Gamma-Metrics in January
   1993, Spectra-Physics Analytical in February 1993, and divisions of FAG
   Kugelfischer Georg Shafer AG in October 1993. The remainder of the increase
   was due to increased demand for products from existing businesses. Segment
   income margin was 17.7%, compared with 17.1% in 1992. Segment income margin
   improved principally due to changes in product mix and continuing efforts
   to reduce costs.
        Sales from the Alternative-energy Systems segment were $242.7 million,
   an increase of $20.8 million, or 9%, over 1992. Sales from Thermo Ecotek
   were $117.7 million, compared with $104.8 million in 1992. Included in
   Thermo Ecotek's 1993 sales was $9.8 million recorded as a result of the
   termination of a power sales contract, and $3.1 million from the one-time
   sale of gas pipeline rights. The 1992 period included $2.0 million received
   in settlement of a dispute over lost development fees. Excluding the
   nonrecurring items from both years, revenues from plant operations
   increased 2% as a result of annual contractual energy rate increases under
   certain power sales contracts, offset in part by increased utility-imposed
   curtailments of power output at two California plants. Construction
   revenues from an alternative-energy facility, which was completed in 1993,
   were $10.9 million, compared with $35.8 million in 1992. Sales from Thermo
   Power were $77.4 million, compared with $43.9 million in 1992. This
   increase results principally from the acquisition of FES by Thermo Power in
   October 1992, offset in part by slight declines in revenues from its
   Crusader Engines and Tecogen divisions. Sales of Peter Brotherhood steam
   turbines and compressors were slightly below 1992 levels.
        Segment income from the Alternative-energy Systems segment was $14.4
   million, compared with $1.8 million in 1992. Thermo Ecotek segment income
   was $13.2 million, compared with $5.7 million in 1992. The 1993 period
   included $8.6 million of income from the termination of a power sales
   contract and the one-time sale of gas pipeline rights. The 1992 period
   included $2.0 million received in settlement of a dispute over lost
   development fees. Excluding the nonrecurring items in both years, segment
   income from Thermo Ecotek was $4.6 million in 1993 and $3.7 million in
   1992. This improvement resulted from lower lease expense, offset in part by
   depreciation expense, resulting from the September 1992 purchase of the
   Whitefield, New Hampshire plant and the December 1993 purchase of the
   Delano I facility. In addition, segment income from Thermo Ecotek was
   favorably affected by contractual energy rate increases. These improvements
   were partially offset by utility-imposed curtailments of power output at
   two California plants, and higher maintenance costs in 1993 to implement
   equipment modifications at one California plant. Total curtailments of
   power output in 1993 were approximately 90% of the maximum allowable
   curtailments under the Company's agreements with the utility, compared with
   less than 10% in 1992. In 1992, Alternative-energy Systems segment income
   reflected the establishment of a reserve of $5.0 million for probable cost
   overruns on projects under construction. Segment income at Thermo Power
   improved principally as a result of increased revenues at FES and efforts
   to reduce costs, offset by a decline at Peter Brotherhood due to lower
   sales and increased price competition.

                                       40PAGE
<PAGE>
   Thermo Electron Corporation


        Sales in the Process Equipment segment were $167.5 million, compared
   with $160.5 million in 1992. Within this segment, sales from Thermo
   Fibertek were $137.1 million, compared with $125.6 million in 1992. Sales
   at Thermo Fibertek increased by $18.6 million as a result of the
   acquisition of AES in June 1993, by $9.7 million due to the inclusion for a
   full year of Vickerys Holdings Limited, which was acquired in September
   1992, and by $4.5 million from the North American accessories,
   flotation-dryer, and pollution-control equipment businesses. These
   increases were partially offset by a decline in sales of $14.6 million in
   Thermo Fibertek's paper-recycling equipment business, which was affected by
   the poor financial condition of the paper industry, particularly in Europe,
   and by the unfavorable effects of a stronger U.S. dollar upon currency
   translation, which decreased sales by approximately $3.7 million. Sales of
   Holcroft heat-treating systems, which remain depressed, were $16.1 million,
   compared with $15.4 million in 1992. Sales of automated electroplating
   equipment from Napco declined to $14.3 million from $19.5 million in 1993,
   due to continuing weak demand. The Process Equipment segment income margin
   was 8.3%, compared with 8.7% in 1992. Thermo Fibertek's segment income
   margin was 11.6%, compared with 12.5% in 1992. This decline was primarily
   due to lower sales of paper-recycling equipment and, to a lesser extent,
   competitive pricing pressure experienced by foreign paper-recycling
   operations. Segment income improved at Holcroft, resulting from reduced
   costs, offset by a decline at Napco. Napco incurred a segment loss of $1.5
   million, compared with income of $0.6 million in 1992, as a result of lower
   sales, pricing pressure, and increased costs to complete jobs.
        Sales in the Biomedical Products segment were $127.5 million, compared
   with $58.2 million in 1992. Sales increased $59.1 million due to the
   inclusion of sales for a full year from Lorad Corporation, a manufacturer
   of mammography and needle-biopsy systems acquired by the Company's
   ThermoTrex subsidiary in November 1992, and from the acquisition of
   Nicolet's biomedical products business as part of the acquisition of
   Nicolet in August 1992. Sales also increased $4.2 million from the
   introduction of Thermedics' Scent Seal fragrance samplers, which were
   developed from the Company's polymer technology, with the balance of the
   increase primarily from higher demand for blood coagulation-monitoring
   products at International Technidyne. Segment income improved to $5.8
   million from $1.3 million in 1992, principally as a result of increased
   sales.
        Sales in the Environmental Services segment were $122.0 million,
   compared with $114.3 million in 1992. Within this segment, sales from
   Thermo Remediation increased by $8.9 million, primarily as a result of
   higher production at soil-remediation centers. Sales of metallurgical
   services declined by $1.3 million due to continuing weakness in aerospace
   and defense-related businesses. Sales from analytical laboratory and
   environmental consulting services were about the same level as in 1992.
   Segment income margin improved to 7.6%, compared with 7.4% in 1992, due to
   an improved sales mix and efforts to reduce costs.
        Sales from the Advanced Technologies segment were $181.1 million,
   compared with $96.3 million in 1992. Revenues from Coleman Research's
   government-sponsored research and development contracts increased $54.5
   million. Sales increased $24.4 million due to increased demand, principally
   from one customer, for Thermedics' process detection instruments. Sales
   also increased $7.2 million at Thermo Voltek, due to the inclusion, for a
   full year, of revenues from KeyTek Instrument, which was acquired in June
   1992, and the inclusion of revenues from Comtest, which was acquired in
   August 1993. These increases were offset in part by a decline in sales from
   a specific contract at Thermo Voltek's Universal Voltronics division, which


                                       41PAGE
<PAGE>
   Thermo Electron Corporation


   was essentially complete in 1993. Segment income was $8.3 million, compared
   with $2.5 million in 1992, resulting primarily from increased sales.
        In 1993, the Company recorded $6.6 million of "Costs associated with
   divisional and product restructuring," which is described in Note 12 to
   Consolidated Financial Statements. Of the $6.6 million, the Alternative-
   energy Systems segment recorded $1.5 million, the Process Equipment segment
   recorded $0.5 million, and the Environmental Services segment recorded $4.6
   million. There were no such costs recorded in 1992. Such amounts were not
   included in segment income discussed above.
        As a result of the sale of stock by subsidiaries, the issuance of
   stock by subsidiaries upon conversion of indebtedness, and similar
   transactions, the Company recorded gains of $39.9 million in 1993 and $30.2
   million in 1992. See Notes 1 and 10 to Consolidated Financial Statements
   for a more complete description of these transactions.
        "Other income (expense), net" in the accompanying statement of income
   includes equity in losses of unconsolidated subsidiaries, which represents
   the Company's portion of results from entities in which the Company's
   ownership is 50% or less, primarily the operation of the Dade County
   cogeneration facility. The loss in 1993 was $22.7 million, compared with a
   loss of $3.9 million in 1992, with the Dade County cogeneration facility
   accounting for $20.7 million and $3.4 million of these losses,
   respectively. The Dade County loss for 1993 includes a provision of $15.0
   million which is discussed above in the 1994 results of operations. The
   remaining increase resulted from higher fuel costs and legal expenses
   pertaining to the legal actions described in Note 7 to Consolidated
   Financial Statements.

   Financial Condition

   Liquidity and Capital Resources
   -------------------------------

   Consolidated working capital was $1,150.7 million at December 31, 1994,
   compared with $833.8 million at January 1, 1994. Included in working
   capital were cash and short-term investments of $997.9 million at December
   31, 1994, compared with $700.4 million at January 1, 1994. In addition, at
   December 31, 1994, the Company had $62.5 million of long-term marketable
   securities, compared with $43.6 million at January 1, 1994. In April 1994,
   the Company issued $345.0 million principal amount of 5% senior convertible
   debentures due 2001.
        In 1994, the Company expended $174.3 million for acquisitions and
   $65.5 million for purchases of property, plant and equipment. The Company
   has no material commitments for purchases of property, plant and equipment
   and expects that, for 1995, such expenditures will approximate the 1994
   level. On March 1, 1995, the Company's Thermo Instrument subsidiary entered
   into an agreement to acquire the Scientific Instruments Division of Fisons
   plc for 202 million British pounds sterling, subject to the satisfaction of
   certain conditions to closing (see Note 15 to Consolidated Financial
   Statements).
        A substantial percentage of the Company's consolidated cash and
   short-term investments is held by subsidiaries that are not wholly owned by
   the Company. This percentage may vary significantly over time. Pursuant to
   the Thermo Electron Corporate Charter (the Charter), to which each of the
   majority-owned subsidiaries of the Company is a party, the combined
   financial resources of Thermo Electron Corporation and its subsidiaries
   allow the Company to provide banking, credit, and other financial services
   to its subsidiaries so that each member of the Thermo Electron group of
   companies may benefit from the financial strength of the entire

                                       42PAGE
<PAGE>
   Thermo Electron Corporation


   organization. Toward that end, the Charter states that each member of the
   group may be required to provide certain credit support to the consolidated
   entity. Nonetheless, the Company's ability to access assets held by its
   majority-owned subsidiaries through dividends, loans, or other transactions
   is subject in each instance to a fiduciary duty owed to the minority
   shareholders of the relevant subsidiary. In addition, dividends received by
   Thermo Electron from a subsidiary that does not consolidate with Thermo
   Electron for tax purposes are subject to tax. Therefore, under certain
   circumstances, a portion of the Company's consolidated cash and short-term
   investments may not be readily available to Thermo Electron or certain of
   its subsidiaries.
        The Company intends for the foreseeable future to maintain at least
   80% ownership of its Thermo Instrument, Thermo Fibertek, and Thermo Ecotek
   subsidiaries, which is required in order to continue to file a consolidated
   federal income tax return with these subsidiaries. In addition, the Company
   intends to maintain greater than 50% ownership of its other majority-owned
   subsidiaries so that the Company may continue to consolidate these
   subsidiaries for financial reporting purposes. This may require the
   purchase by the Company of additional shares or convertible debentures of
   these companies from time to time as the number of outstanding shares
   issued by these companies increases, either in the open market or directly
   from the subsidiaries. See Note 6 to Consolidated Financial Statements for
   a description of outstanding convertible debentures issued by Thermo
   Instrument. In addition, at December 31, 1994, Thermo Instrument, Thermo
   Fibertek, and Thermo Ecotek had outstanding stock options of 2,026,000
   shares, 1,681,000 shares, and 1,026,000 shares, respectively, exercisable
   at various prices and subject to certain vesting schedules. The Company's
   other majority-owned subsidiaries also have outstanding stock options
   and/or convertible debentures. If the Company were to lose its ability to
   consolidate for tax purposes with Thermo Instrument, the Company would
   incur an additional tax liability, which could be substantial.
        During 1994, the Company and its majority-owned subsidiaries expended
   $101.5 million to purchase common stock of the Company's subsidiaries. The
   Company expects that these purchases will continue in 1995.

























                                       43PAGE
<PAGE>
   Thermo Electron Corporation

   Information as to Publicly Owned Businesses (Unaudited)

   (In thousands)                           1994         1993        1992
   ----------------------------------------------------------------------
   Revenues:
    Thermo Instrument Systems Inc.    $  662,187  $  584,176   $  423,199
    Thermo Fibertek Inc.                 162,625     137,088      125,577
    Thermedics Inc. (a)                  155,111      80,220       45,778
    Thermo Ecotek Corporation            134,261     117,691      104,785
    Thermo Process Systems Inc. (b)      111,268      53,839       47,082
    Thermo Power Corporation              91,873      77,360       43,904
    ThermoTrex Corporation (c)            91,052      54,329       19,843
                                      ----------  ----------   ----------
                                       1,408,377   1,104,703      810,168
   Wholly owned nonpublic companies      320,814     249,805      189,060
                                      ----------  ----------   ----------
                                      $1,729,191  $1,354,508   $  999,228
                                      ==========  ==========   ==========
   Segment Income (d):
    Thermo Instrument Systems Inc.    $  106,241  $   96,786   $   63,373
    Thermo Fibertek Inc.                  20,948      15,902       15,716
    Thermedics Inc. (a)                   16,909       8,292          841
    Thermo Ecotek Corporation             26,928      13,184        5,735
    Thermo Process Systems Inc. (b)        9,219       1,338          371
    Thermo Power Corporation               5,263       2,707          715
    ThermoTrex Corporation (c)             1,467         485       (1,185)
                                      ----------  ----------   ----------
                                         186,975     138,694       85,566
   Wholly owned nonpublic companies       19,313       4,357        2,029
                                      ----------  ----------   ----------
                                         206,288     143,051       87,595
   Equity in Losses of
    Unconsolidated Subsidiaries           (4,019)    (22,721)      (3,948)
   Corporate                               4,107      11,137       18,928
                                      ----------  ----------   ----------
   Income Before Income Taxes,
    Minority Interest, and
    Cumulative Effect of Change
    in Accounting Principle           $  206,376  $  131,467   $  102,575
                                      ==========  ==========   ==========

   (a)  Includes Thermo Cardiosystems Inc. and Thermo Voltek Corp.
   (b)  Includes Thermo Remediation Inc.
   (c)  Includes ThermoLase Corporation.
   (d)  Segment income is income before corporate general and administrative
        expenses, costs associated with divisional and product restructuring,
        other income and expense, minority interest expense, and income taxes.












                                       44PAGE
<PAGE>
   Thermo Electron Corporation

   Quarterly Information (Unaudited)

   (In thousands except per share amounts)

   1994(a)                               First    Second     Third    Fourth
   -------------------------------------------------------------------------
   Revenues                           $383,724  $428,547  $445,516  $471,404
   Gross profit                        140,020   159,736   171,114   180,031
   Net income                           22,925    24,418    27,827    29,541
   Earnings per share:
    Primary                                .30       .32       .35       .37
    Fully diluted                          .27       .28       .31       .33



   1993(b)                               First    Second     Third    Fourth
   -------------------------------------------------------------------------
   Revenues                           $310,294  $324,805  $350,360  $369,049
   Gross profit                        106,904   112,233   126,966   136,179
   Net income                           15,515    17,682    20,977    22,694
   Earnings per share:
    Primary                                .24       .27       .29       .30
    Fully diluted                          .22       .25       .26       .27

   (a)  Results include nontaxable gains of $8,494,000, $229,000, $12,561,000,
        and $3,999,000 in the first, second, third, and fourth quarters,
        respectively, from the issuance of stock by subsidiaries.
   (b)  Results include nontaxable gains of $11,101,000, $10,617,000,
        $3,461,000, and $14,684,000 in the first, second, third, and fourth
        quarters, respectively, from the issuance of stock by subsidiaries.


   Common Stock Market Information
   --------------------------------------------------------------------------
   The following table shows the market range for the Company's common stock
   based on reported sales prices on the New York Stock Exchange (symbol TMO)
   for 1994 and 1993. Prices were restated in 1993 to reflect a three-for-two
   stock split distributed in October 1993.

                                             1994                1993
                                      ----------------    ----------------
   Quarter                             High       Low      High      Low
   -----------------------------------------------------------------------
   First                              $29 3/5   $25 1/3   $25 1/3   $20 8/9
   Second                              27 3/5    24        27 4/9    24 2/9
   Third                               30 3/5    25 1/4    28 5/6    24 5/6
   Fourth                              31 11/12  27 1/6    28 2/3    25 2/5

        The closing market price on the New York Stock Exchange for the
   Company's common stock on January 27, 1995 was $29 3/5 per share.
        As of January 27, 1995, the Company had 6,666 holders of record of its
   common stock. This does not include holdings in street or nominee names.








                                       45PAGE
<PAGE>
   Thermo Electron Corporation


        Common stock of the following majority-owned public subsidiaries is
   traded on the American Stock Exchange: Thermedics Inc. (TMD), Thermo
   Instrument Systems Inc. (THI), Thermo Process Systems Inc. (TPI), Thermo
   Power Corporation (THP), ThermoTrex Corporation (TKN), Thermo Fibertek Inc.
   (TFT), Thermo Ecotek Corporation (TCK), Thermo Cardiosystems Inc. (TCA),
   Thermo Voltek Corp. (TVL), Thermo Remediation Inc. (THN), and ThermoLase
   Corporation (TLZ).


   Transfer Agent and Common Stock Registrar
   --------------------------------------------------------------------------
   The Bank of Boston is the stock transfer agent and maintains shareholder
   activity records. The agent will respond to questions on issuances of stock
   certificates, changes of ownership, lost stock certificates, and changes of
   address. For these and similar matters, please direct inquiries to:

               The Bank of Boston
               Post Office Box 644
               Mail Stop: 45-02-09
               Boston, Massachusetts 02102-0644
               (617) 575-3120


   Shareholder Services
   --------------------------------------------------------------------------
   Shareholders of Thermo Electron Corporation who desire information about
   the Company are invited to contact John N. Hatsopoulos, Chief Financial
   Officer, Thermo Electron Corporation, 81 Wyman Street, P.O. Box 9046,
   Waltham, Massachusetts 02254-9046, by letter or telephone at 
   (617) 622-1111.
        A mailing list is maintained to enable shareholders whose stock is
   held in street name, and other interested individuals, to receive quarterly
   and annual reports as quickly as possible. If you would like your name
   added to the list, please notify this office.


   Dividend Policy
   --------------------------------------------------------------------------
   The Company has never paid cash dividends and does not expect to pay cash
   dividends in the foreseeable future because its policy has been to use
   earnings to finance expansion and growth. Payment of dividends will rest
   within the discretion of the Board of Directors and will depend upon, among
   other factors, the Company's earnings, capital requirements, and financial
   condition.


   Annual Meeting
   --------------------------------------------------------------------------
   The annual meeting of shareholders will be held on Tuesday, May 23, 1995 at
   5:00 p.m. at the Hyatt Regency Hotel, Hilton Head, South Carolina.









                                       46PAGE
<PAGE>
   Thermo Electron Corporation


   Form 10-K Report
   --------------------------------------------------------------------------
   A copy of the Annual Report on Form 10-K for the fiscal year ended December
   31, 1994, as filed with the Securities and Exchange Commission, may be
   obtained at no charge by writing to John N. Hatsopoulos, Chief Financial
   Officer, Thermo Electron Corporation, 81 Wyman Street, P.O. Box 9046,
   Waltham, Massachusetts 02254-9046.


   Corporate Office
   --------------------------------------------------------------------------
               Thermo Electron Corporation
               81 Wyman Street
               Post Office Box 9046
               Waltham, Massachusetts 02254-9046












































                                       47PAGE
<PAGE>
Thermo Electron Corporation

<TABLE>
Ten Year Financial Summary
(In millions except per share amounts)
<CAPTION>
                   1994(a)   1993(b)  1992(c)  1991(d) 1990(e)    1989    1988    1987     1986     1985
                   ------   -------  -------  ------- -------  ------- ------- -------  -------  -------
<S>              <C>       <C>       <C>      <C>     <C>      <C>     <C>     <C>      <C>      <C>
Revenues         $1,729.2  $1,354.5  $ 999.2  $ 842.5 $ 744.5  $ 640.3 $ 553.7 $ 430.8  $ 368.0  $ 291.1
                 --------  --------  -------  ------- -------  ------- ------- -------  -------  -------
Costs and Expenses:
 Cost of revenues   928.6     755.5    609.0    532.9   465.1    424.2   359.6   280.3    244.8    194.9
 Expenses for R&D                                                                
  and new lines of
  business          233.1     183.9    106.5     84.6    74.5     60.7    54.3    40.9     33.9     25.3
 Selling, general                                                                 
  and administra-
  tive expenses     384.7     289.3    213.2    177.7   163.0    129.6   113.1    90.4     71.7     56.3
 Costs associated                                                                 
  with divisional  
  and product
  restructuring        .7       6.6        -      3.7     1.0      2.2     0.9     3.4      7.1      4.3
                  -------  --------  -------  ------- -------  ------- ------- -------  -------  -------
                  1,547.1   1,235.3    928.7    798.9   703.6    616.7   527.9   415.0    357.5    280.8
                  -------  --------  -------  ------- -------  ------- ------- -------  -------  -------
Operating Income    182.1     119.2     70.5     43.6    40.9     23.6    25.8    15.8     10.5     10.3

Gain on Issuance 
 of Stock by
 Subsidiaries        25.3      39.8     30.2     27.4    20.3     16.8     6.0    16.1     15.9      9.1
Other Income                                                                      
 (Expense), Net      (1.0)    (27.5)     1.8     10.6    (0.5)     1.1     2.8    (2.5)    (5.1)    (5.9)
                  -------  --------  -------  ------- -------  ------- ------- -------  -------  -------
Income Before                                                                      
 Income Taxes,
 Minority Interest,
 and Cumulative
 Effect of Change
 in Accounting
 Principle          206.4     131.5    102.5     81.6    60.7     41.5    34.6    29.4     21.3     13.5
Provision for                                                                              
 Income Taxes        70.7      33.5     27.7     25.8    18.1     10.9     9.2     6.3      4.4      2.7
Minority Interest                                                                           
 Expense             31.0      21.1     13.9      7.3     7.1      3.3     2.1     1.9      0.5     (0.1)
                  -------  --------  -------  ------- -------  ------- ------- -------  -------  -------
                                                       



                                                    48PAGE
<PAGE>
Thermo Electron Corporation

Ten Year Financial Summary (continued)
(In millions except per share amounts)

                   1994(a)   1993(b)  1992(c)  1991(d) 1990(e)    1989    1988    1987     1986     1985
                   ------   -------  -------  ------- -------  ------- ------- -------  -------  -------
Income Before 
 Cumulative Effect  
 of Change in
 Accounting
 Principle          104.7      76.9     60.9     48.5    35.5     27.3    23.3    21.2     16.4     10.9
Cumulative Effect                                                                  
 of Change in 
 Accounting Prin-
 ciple, Net of
 Tax (f)                -         -      1.4        -       -        -       -       -        -        -
                 --------  --------  -------  ------- -------  ------- ------- -------  -------  -------
Net Income       $  104.7  $   76.9  $  59.5  $  48.5 $  35.5  $  27.3 $  23.3 $  21.2  $  16.4  $  10.9
                 ========  ========  =======  ======= =======  ======= ======= =======  =======  =======    
Earnings per                                                                   
 Share Before
 Cumulative
 Effect of
 Change in
 Accounting
 Principle:
  Primary        $   1.35  $   1.11  $   .95  $   .84 $   .68  $   .55 $   .48 $   .43  $   .34  $   .27
  Fully                                                                       
   diluted       $   1.20  $   1.00  $   .90  $   .79 $   .65  $   .53 $   .48 $   .43  $   .34  $   .26

Earnings per
 Share:
  Primary        $   1.35  $   1.11  $   .93  $   .84 $   .68  $   .55 $   .48 $   .43  $   .34  $   .27
  Fully                                                                                 
   diluted       $   1.20  $   1.00  $   .88  $   .79 $   .65  $   .53 $   .48 $   .43  $   .34  $   .26







                                                    49PAGE
<PAGE>
Thermo Electron Corporation


Ten Year Financial Summary (continued)
(In millions except per share amounts)

                   1994(a)   1993(b)  1992(c)  1991(d) 1990(e)    1989    1988    1987     1986     1985
                   ------   -------  -------  ------- -------  ------- ------- -------  -------  -------
Balance Sheet
 Data:
  Working
   capital       $1,150.7  $  833.8 $  508.7 $  468.4 $ 244.1  $ 277.6 $ 220.1 $ 211.8  $ 124.5  $  79.6
  Total assets    3,061.9   2,507.6  1,838.0  1,212.5   912.0    669.9   528.5   465.0    336.0    243.1
  Net assets                                                                             
   related to
   construc-
   tion
   projects             -       9.4     23.8     29.4       -        -       -       -        -        -
  Long-term                                                                           
   obligations    1,049.9     647.6    494.2    255.1   210.5    177.0   152.9   136.1     61.4     49.5
  Minority                                                                        
   interest         327.7     277.7    164.3    122.5    83.9     51.8    22.6    25.8     20.1      6.6
  Common stock                                                                     
   of subsid-
   iaries
   subject to
   redemption           -      14.5      5.5      5.5     8.7     13.1       -       -        -        -
  Shareholders'                                                                                          
   investment     1,007.5     873.7    563.8    489.5   314.1    229.2   196.4   175.3    154.5    107.7
<FN>
(a)  Reflects the issuance of $345.0 million principal amount of convertible debentures.
(b)  Reflects the Company's 1993 public offering of common stock for net proceeds of $246.0 million.
(c)  Reflects the August 1992 acquisition of Nicolet Instrument Corporation and the issuance of $260.0
     million principal amount of convertible debentures.
(d)  Reflects the issuance of $164.0 million principal amount of convertible debentures.
(e)  Reflects the May 1990 acquisition of Finnigan Corporation.
(f)  Reflects the adoption in fiscal 1992 of Statement of Financial Accounting Standards No. 106,
     "Accounting for Post-retirement Benefits Other Than Pensions".

</TABLE>
                                                    50<PAGE>

                                                                    Exhibit 23




                    Consent of Independent Public Accountants


   As independent public accountants, we hereby consent to the incorporation
   by reference of our reports dated February 10, 1995 (except with respect to
   the matters discussed in Note 15 as to which the date is July 20, 1995)
   included in or incorporated by reference into Thermo Electron Corporation's
   Annual Report on Amendment No. 2 on Form 10-K/A for the year ended December
   31, 1994 into the Company's previously filed Registration Statement 
   No. 33-00182 on Form S-8, Registration Statement No. 33-8993 on Form S-8,
   Registration Statement No. 33-8973 on Form S-8, Registration Statement 
   No. 33-16460 on Form S-8, Registration Statement No. 33-16466 on Form S-8,
   Registration Statement No. 33-25052 on Form S-8, Registration Statement 
   No. 33-37865 on Form S-8, Registration Statement No. 33-37867 on Form S-8,
   Registration Statement No. 33-36223 on Form S-8, Registration Statement 
   No. 33-52826 on Form S-8, Registration Statement No. 33-52804 on Form S-8,
   Registration Statement No. 33-52806 on Form S-8, Registration Statement 
   No. 33-52800 on Form S-8, Registration Statement No. 33-37868 on Form S-3,
   Registration Statement No. 33-35657 on Form S-3, Registration Statement 
   No. 33-34752 on Form S-3, Registration Statement No. 33-39434 on Form S-3,
   Registration Statement No. 33-12748 on Form S-3, Registration Statement 
   No. 33-39773 on Form S-3, Registration Statement No. 33-40669 on Form S-3,
   Registration Statement No. 33-41256 on Form S-3, Registration Statement 
   No. 33-42694 on Form S-3, Registration Statement No. 33-43706 on Form S-3,
   Registration Statement No. 33-45401 on Form S-3, Registration Statement 
   No. 33-45603 on Form S-3, Registration Statement No. 33-50924 on Form S-3,
   Registration Statement No. 33-51187 on Form S-8, Registration Statement 
   No. 33-51189 on Form S-8, Registration Statement No. 33-54185 on Form S-3,
   Registration Statement No. 33-54347 on Form S-8, Registration Statement 
   No. 33-54453 on Form S-8, Registration Statement No. 33-57129 on Form S-4,
   Registration Statement No. 33-59544 on Form S-3, and Registration Statement
   No. 33-58487 on Form S-8.



                                               Arthur Andersen LLP



   Boston, Massachusetts
   August 1, 1995
   <PAGE>

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THERMO
ELECTRON CORPORATION'S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER
31, 1994 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<RESTATED> 
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1994
<PERIOD-END>                               DEC-31-1994
<CASH>                                         383,005
<SECURITIES>                                   614,915
<RECEIVABLES>                                  347,444
<ALLOWANCES>                                    21,664
<INVENTORY>                                    233,382
<CURRENT-ASSETS>                             1,711,624
<PP&E>                                         811,325
<DEPRECIATION>                                 186,437
<TOTAL-ASSETS>                               3,061,935
<CURRENT-LIABILITIES>                          560,892
<BONDS>                                      1,049,850
<COMMON>                                        53,558
                                0
                                          0
<OTHER-SE>                                     953,928
<TOTAL-LIABILITY-AND-EQUITY>                 3,061,935
<SALES>                                      1,418,306
<TOTAL-REVENUES>                             1,729,191
<CGS>                                          824,845
<TOTAL-COSTS>                                1,078,290<F1>
<OTHER-EXPENSES>                                84,104<F2>
<LOSS-PROVISION>                                 4,255
<INTEREST-EXPENSE>                              59,844
<INCOME-PRETAX>                                206,376
<INCOME-TAX>                                    70,703
<INCOME-CONTINUING>                            104,711
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   104,711
<EPS-PRIMARY>                                     1.35
<EPS-DILUTED>                                     1.20
<FN>
<F1>THIS LINE IS MADE UP OF THE FOLLOWING INCOME STATEMENT ACCOUNTS: "COST OF
PRODUCTS", "COST OF SERVICES", AND "RESEARCH AND DEVELOPMENT CONTRACTS".
<F2>THIS LINE IS MADE UP OF THE FOLLOWING INCOME STATEMENT ACCOUNTS: "COSTS
ASSOCIATED WITH DIVISIONAL AND PRODUCT RESTRUCTURING", "INTERNALLY FUNDED
RESEARCH AND DEVELOPMENT" AND "OTHER EXPENSES FOR NEW LINES OF BUSINESS".
</FN>
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission